Asthma mixed form (mode)

ASTHMA_MIXED

asthma: A bronchial disease that is characterized by chronic inflammation and narrowing of the airways, which is caused by a combination of environmental and genetic factors resulting in recurring periods of wheezing (a whistling sound while breathing), chest tightness, shortness of breath, mucus production and coughing. The symptoms appear due to a variety of triggers such as allergens, irritants, respiratory infections, weather changes, exercise, stress, reflux disease, medications, foods and emotional anxiety.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Check mode of ICD-10 codes: %J458 Registry filters: Hospital discharge: ICD-10 — J45.8 Cause of death: ICD-10 — J45.8 2 out of 7 registries used, show all original rules.	2468
4. Check minimum number of events None	2468
5. Include endpoints None	2468
6. Filter based on genotype QC (FinnGen only)	2468

Control definitions (FinnGen only)

Control exclude: J10_ASTHMA, ASTHMA_EXCL

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	ASTHMA_MIXED
CONTROL_EXCLUDE	J10_ASTHMA\|ASTHMA_EXCL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	%J458
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	%J458
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Asthma mixed form (mode) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Asthma mixed form (mode), excluding more controls

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2468	1461	1007
Unadjusted period prevalence (%)	0.48	0.50	0.44
Median age at first event (years)	53.62	49.30	59.88

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2227: Matched controls
22262

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

69.5

323.0

503

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

55.7

323.0

517

120

R03BA01

ATC

beclometasone; inhalant

16.5

323.0

809

742

R03AK07

ATC

formoterol and budesonide; inhalant

11.1

323.0

860

1189

R03AC02

ATC

salbutamol; inhalant

31.7

323.0

2034

5547

R03AC12

ATC

salmeterol; inhalant

68.7

323.0

392

J45.8

ICD-10 Finland

Mixed asthma

+∞

323.0

2227

J45.9

ICD-10 Finland

Asthma, unspecified

81.2

323.0

1252

347

H02AB06

ATC

prednisolone; systemic

10.3

323.0

1621

4592

R96

ICPC

Asthma

22.1

323.0

500

288

J18.9

ICD-10 Finland

Pneumonia, unspecified

23.4

323.0

627

366

R03AK06

ATC

salmeterol and fluticasone; inhalant

31.0

323.0

977

547

J45.0

ICD-10 Finland

Predominantly allergic asthma

148.0

323.0

629

R03DC03

ATC

montelukast; oral

20.3

323.0

967

812

R03BA02

ATC

budesonide; inhalant

15.0

323.0

923

1002

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

148.9

323.0

1766

560

R03BA05

ATC

fluticasone; inhalant

16.5

323.0

1034

1111

R03BB04

ATC

tiotropium bromide; inhalant

55.8

323.0

597

145

J45.1

ICD-10 Finland

Nonallergic asthma

134.3

323.0

416

R03AC03

ATC

terbutaline; inhalant

10.9

313.2

661

832

R03DA04

ATC

theophylline; systemic, rectal

29.3

281.9

388

159

J45

ICD-10 Finland

Asthma

17.4

276.7

456

325

XG474

NOMESCO Finland

Exhalation nntrogen oxide

79.5

242.6

273

R03AC13

ATC

formoterol; inhalant

32.9

231.2

308

108

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

151.5

208.6

219

R03BA08

ATC

ciclesonide; inhalant

14.3

204.4

363

299

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

115.8

194.9

210

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

6.8

194.0

548

1018

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

56.8

193.9

230

R03AK08

ATC

formoterol and beclometasone; inhalant

38.8

190.0

243

UGC12

NOMESCO Finland

Flexible bronchoscopy

23.1

189.5

279

137

J46

ICD-10 Finland

Status asthmaticus

166.9

176.4

184

R06.0

ICD-10 Finland

Dyspnoea

4.7

168.5

678

1879

J01AA02

ATC

doxycycline; systemic

3.9

163.7

1791

11413

R01AD08

ATC

fluticasone; nasal

4.2

163.5

780

2540

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

25.8

163.3

232

100

R06AE07

ATC

cetirizine; oral

3.4

157.2

1162

5394

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

33.6

155.1

205

J01FA06

ATC

roxithromycin; oral

3.5

153.1

1032

4437

XG410

NOMESCO Finland

Flow-volume spirometry

26.9

147.0

206

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

386.8

146.8

146

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

216.3

138.5

142

XG470

NOMESCO Finland

Measurement of diffusion capastity of the lungs

43.2

134.6

168

R01AD09

ATC

mometasone; nasal

3.1

133.5

1068

5054

H02AB04

ATC

methylprednisolone; systemic

5.2

130.4

454

1044

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

14.2

130.1

229

178

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

10.0

129.4

273

308

R01AD01

ATC

beclometasone; nasal

4.7

129.0

503

1305

R06.2

ICD-10 Finland

Wheezing

16.6

128.7

212

140

ZX109

NOMESCO Finland

Instruction on medicine inhalation technique

175.1

126.8

132

49300

ICD-8 Finland

Asthma, bronchiale

+∞

126.2

120

4939X

ICD-9 Finland

Asthma, unspecified[ASTHMA BRONCHIALE NUD]

+∞

125.2

119

XQ800

NOMESCO Finland

Prick test

8.3

124.5

293

398

J01MA14

ATC

moxifloxacin; systemic

8.8

117.9

267

339

XG405

NOMESCO Finland

Education on PEF monitoring

73.6

115.9

132

R03BB01

ATC

ipratropium bromide; inhalant

17.2

114.8

186

117

Z01.8

ICD-10 Finland

Other specified special examinations

3.6

113.4

609

2083

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

12.6

113.3

210

182

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.8

104.4

984

4934

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

155.6

99.0

104

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.7

96.0

494

1607

J01FA10

ATC

azithromycin; systemic

2.5

95.5

1330

8191

R03AK11

ATC

formoterol and fluticasone; inhalant

25.4

94.5

134

J96.1

ICD-10 Finland

Chronic respiratory failure

902.8

89.3

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.5

89.0

1132

6538

R03DC01

ATC

zafirlukast; oral

42.8

88.2

110

J01FA09

ATC

clarithromycin; systemic

2.8

86.8

745

3435

H02AB07

ATC

prednisone; oral

4.1

86.2

381

1078

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

5.3

85.7

281

586

R01AD12

ATC

fluticasone furoate; nasal

2.8

84.7

680

3001

J31.0

ICD-10 Finland

Chronic rhinitis

10.9

84.6

168

166

R06AX27

ATC

desloratadine; oral

2.8

83.4

666

2924

SPAT1059

SPAT

Spirometry at the office

7.6

83.4

206

296

R03BC03

ATC

nedocromil; inhalant

5.7

83.0

256

496

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

3.3

82.3

491

1768

RD211

NOMESCO Finland

6.7

81.8

221

361

Z71.8

ICD-10 Finland

Other specified counselling

2.8

81.6

648

2828

J47

ICD-10 Finland

Bronchiectasis

411.7

80.4

TDM10

NOMESCO Finland

Puncture of maxillary antrum

91.6

79.5

S01GX01

ATC

cromoglicic acid; ophthalmic

3.1

78.4

518

1997

J33.0

ICD-10 Finland

Polyp of nasal cavity

98.1

77.5

4930A

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

73.3

R03AK04

ATC

salbutamol and sodium cromoglicate; inhalant

+∞

72.3

R02

ICPC

Shortness of breath/dyspnoea

4.2

69.6

289

763

R06AX13

ATC

loratadine; oral

3.3

68.1

401

1408

R01AD11

ATC

triamcinolone; nasal

4.6

66.3

250

600

EMB10

NOMESCO Finland

Tonsillectomy

48.7

65.9

SPAT1058

SPAT

PEF monitoring instruction

4.9

65.5

229

508

R95

ICPC

Chron obstructive pulmonary disease

24.5

64.5

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.5

63.8

625

3006

R01BA52

ATC

pseudoephedrine, combinations; oral

2.5

63.5

632

3063

C03CA01

ATC

furosemide; systemic

2.5

63.4

597

2810

Z00.0

ICD-10 Finland

General medical examination

2.7

62.6

518

2261

WZC30

NOMESCO Finland

Teaching

3.3

62.6

350

1178

R01AD05

ATC

budesonide; nasal

4.9

62.6

217

476

J34.2

ICD-10 Finland

Deviated nasal septum

54.6

62.3

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

100.1

62.2

J35.2

ICD-10 Finland

Hypertrophy of adenoids

+∞

61.7

N02AX02

ATC

tramadol; systemic, rectal

2.2

61.2

858

4906

R06AX22

ATC

ebastine; oral

2.9

61.1

418

1620

J35.0

ICD-10 Finland

Chronic tonsillitis

61.0

60.8

UDH02

NOMESCO Finland

Rhinopharyngoscopy

8.6

59.8

134

164

R06AE09

ATC

levocetirizine; oral

3.1

59.5

366

1317

R01AC01

ATC

cromoglicic acid; nasal

7.1

59.0

150

223

J30.3

ICD-10 Finland

Other allergic rhinitis

12.5

59.0

108

R03BC01

ATC

cromoglicic acid; inhalant

17.9

58.9

A02BC02

ATC

pantoprazole; systemic

2.1

58.2

1281

8821

J01CA04

ATC

amoxicillin; systemic

2.2

57.1

1737

13653

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

3.5

56.3

293

931

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

23.3

56.1

J01DA01

ATC

[U] cefalexin; systemic

2.0

55.7

1307

9160

TGC00

NOMESCO Finland

Bronchial lavation

25.6

54.9

R05

ICD-10 Finland

Cough

2.8

54.1

406

1656

A02BC03

ATC

lansoprazole; oral

2.3

53.7

615

3154

R06AX26

ATC

fexofenadine; oral

4.5

53.6

201

477

N02BE01

ATC

paracetamol; systemic, rectal

2.2

53.4

1777

14252

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.2

52.6

651

3457

4930B

ICD-9 Finland

Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

52.3

G47.3

ICD-10 Finland

Sleep apnoea

2.7

51.4

402

1676

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

7.1

51.2

130

193

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

135.6

50.0

C01CA24

ATC

epinephrine; parenteral

4.9

49.8

172

374

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

59.4

49.6

RF410

NOMESCO Finland

12.1

49.6

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.7

49.5

233

679

SPAT1252

SPAT

Overall medication plan or its review

3.9

49.5

219

606

A02BC05

ATC

esomeprazole; systemic

2.1

48.9

793

4710

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

2.1

48.4

719

4114

R04.2

ICD-10 Finland

Haemoptysis

10.4

47.0

R5140

NOMESCO Finland

Monitoring the use of the aid

3.5

46.7

241

756

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

8.2

46.4

106

134

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.0

45.1

726

4267

J90

ICD-10 Finland

Pleural effusion, not elsewhere classified

122.5

44.9

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.9

44.8

893

5697

J01FA15

ATC

telithromycin; oral

3.4

43.8

228

719

RF420

NOMESCO Finland

10.0

43.7

A01AB09

ATC

miconazole; local oral

3.4

43.6

225

705

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

17.5

43.0

R05FB02

ATC

cough suppressants and expectorants

2.0

42.4

760

4636

R05

ICPC

Cough

2.3

42.2

459

2259

C07AB07

ATC

bisoprolol; oral

1.9

42.1

893

5794

DHB20

NOMESCO Finland

Polypectomy of internal nose

93.9

41.9

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

2.2

41.3

478

2419

R03AL06

ATC

olodaterol and tiotropium bromide; inhalant

68.4

41.2

DJD20

NOMESCO Finland

Plastic repair of septum of nose

112.1

40.8

XG466

NOMESCO Finland

Sleep oxymetry

9.0

40.8

101

M54.5

ICD-10 Finland

Low back pain

2.0

40.5

657

3838

J01MA12

ATC

levofloxacin; systemic

2.6

40.1

334

1429

J37.0

ICD-10 Finland

Chronic laryngitis

22.4

39.3

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.4

39.0

388

1820

SPAT1325

SPAT

Vaccination

1.9

38.9

759

4740

J33.8

ICD-10 Finland

Other polyp of sinus

87.7

38.9

J84.9

ICD-10 Finland

Interstitial pulmonary disease, unspecified

+∞

37.6

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

37.4

541

3002

XG460

NOMESCO Finland

Short time oxymetry

16.6

37.3

EMB30

NOMESCO Finland

Adenotomy

13.0

37.1

R51.80

ICD-10 Finland

Headache

2.6

37.0

309

1318

A02BC01

ATC

omeprazole; systemic

2.0

37.0

549

3078

R50.9

ICD-10 Finland

Fever, unspecified

2.8

36.9

265

1035

R05FA02

ATC

opium derivatives and expectorants; systemic

1.8

36.6

819

5342

J01DB01

ATC

cefalexin; oral

1.9

36.4

1641

13396

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

10.2

36.3

J21.9

ICD-10 Finland

Acute bronchiolitis, unspecified

362.7

36.1

E0000UV

ATC

1.8

36.0

807

5255

L20.0

ICD-10 Finland

Besnier prurigo

3.5

35.9

179

544

R03AL02

ATC

salbutamol and ipratropium bromide; inhalant

187.9

35.8

R03BB02

ATC

oxitropium bromide; inhalant

31.9

35.7

N03AX12

ATC

gabapentin; oral

2.5

35.7

308

1339

I50.9

ICD-10 Finland

Heart failure, unspecified

2.8

35.4

242

917

R03CC02

ATC

salbutamol; systemic

3.3

34.9

184

583

J92.0

ICD-10 Finland

Pleural plaque with presence of asbestos

+∞

34.4

4931A

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]

+∞

34.4

D86.0

ICD-10 Finland

Sarcoidosis of lung

+∞

34.4

J09

ICD-10 Finland

Influenza due to identified zoonotic or pandemic influenza virus

42.7

34.1

J01FF01

ATC

clindamycin; systemic

2.0

33.9

502

2797

R03AK

ATC

Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics

94.0

33.8

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

2.2

33.0

398

2031

I50.0

ICD-10 Finland

Congestive heart failure

3.8

32.7

147

410

Z51.6

ICD-10 Finland

Desensitization to allergens

49.5

32.6

J36

ICD-10 Finland

Peritonsillar abscess

55.1

32.3

A02BA02

ATC

ranitidine; systemic

2.1

31.4

390

2013

49302

ICD-8 Finland

Asthma, Rhinitis allergica cum asthmate bronchiali

+∞

31.3

4912B

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS OBSTRUCTIVA CUM EMPHYSEMATE]

+∞

31.3

SPAT1057

SPAT

Peak expiratory flow measurement

7.8

31.3

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

7.5

31.3

103

R06.5

ICD-10 Finland

Mouth breathing

3.2

31.0

169

549

J32.4

ICD-10 Finland

Chronic pansinusitis

316.9

30.9

J02AC01

ATC

fluconazole; systemic

1.8

30.9

768

5110

J01DA06

ATC

[U] cefuroxime; systemic

2.4

30.4

295

1355

M79.6

ICD-10 Finland

Pain in limb

1.8

30.1

657

4186

SPAT1263

SPAT

Sampling

1.7

30.0

840

5781

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

68.9

29.9

SPAT1359

SPAT

Use of symptom diary

5.5

29.9

168

J84.1

ICD-10 Finland

Other interstitial pulmonary diseases with fibrosis

306.2

29.9

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

12.3

29.7

N03AX16

ATC

pregabalin; oral

2.1

29.7

408

2191

SPAT1254

SPAT

Administration of medicine

2.3

29.6

318

1531

HMAK

NOMESCO Finland

2.3

29.5

294

1365

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

3.8

28.8

125

339

N02AJ06

ATC

codeine and paracetamol; systemic

1.8

28.6

676

4400

UDM02

NOMESCO Finland

Sinoscopy

16.2

28.5

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

28.3

314

1534

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.7

28.3

202

783

RF210

NOMESCO Finland

4.7

28.3

214

J96.0

ICD-10 Finland

Acute respiratory failure

+∞

28.2

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

27.9

592

3714

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.2

27.8

315

1556

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

9.5

27.2

E66.01

ICD-10 Finland

Obesity due to excess calories

3.0

27.1

162

561

R81

ICPC

Pneumonia

7.8

27.1

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.5

27.0

232

998

J01MA02

ATC

ciprofloxacin; systemic

1.7

26.3

705

4741

DHB50

NOMESCO Finland

Turbinoplasty

52.3

26.2

A07AA02

ATC

nystatin; oral

3.5

26.2

129

388

S18

ICPC

Laceration/cut

1.7

26.2

779

5401

RF120

NOMESCO Finland

8.4

25.8

T78.4

ICD-10 Finland

Allergy, unspecified

3.9

25.8

108

284

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

25.5

460

2720

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

25.3

642

4240

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

50.6

25.3

A44

ICPC

General and Unspecified, Preventive immunization/medic

2.6

25.1

190

763

J30.1

ICD-10 Finland

Allergic rhinitis due to pollen

+∞

25.0

ZX120

NOMESCO Finland

Intravenous

2.7

24.9

178

689

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.6

24.8

191

774

SPAT1257

SPAT

Teaching of medicine inhalation technique

5.0

24.7

163

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

6.9

24.3

N06AX21

ATC

duloxetine; oral

2.5

24.2

200

842

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.6

24.2

189

A01AB04

ATC

amphotericin B; local oral

3.7

24.0

109

307

J10.0

ICD-10 Finland

Influenza with pneumonia, seasonal influenza virus identified

+∞

24.0

Z25.1

ICD-10 Finland

Need for immunization against influenza

3.1

24.0

136

454

J01FA01

ATC

erythromycin; systemic

2.1

23.9

292

1482

N05BA04

ATC

oxazepam; oral

1.8

23.7

462

2799

J20

ICD-10 Finland

Acute bronchitis

2.7

23.6

168

650

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

22.9

D86.2

ICD-10 Finland

Sarcoidosis of lung with sarcoidosis of lymph nodes

+∞

22.9

N05CF01

ATC

zopiclone; oral

1.7

22.8

580

3814

WQ000

NOMESCO Finland

Hyposensibilisation

84.3

22.7

R60.0

ICD-10 Finland

Localized oedema

2.4

22.5

209

935

J44

ICD-10 Finland

Other chronic obstructive pulmonary disease

12.3

22.3

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.8

22.3

149

556

SPAT1310

SPAT

Counselling related to known health issue

1.7

22.2

632

4281

ZXA10

NOMESCO Finland

Bilateral

2.0

22.2

321

1745

R01AC07

ATC

nedocromil; nasal

21.6

22.1

Z01.1

ICD-10 Finland

Examination of ears and hearing

2.1

21.9

278

1432

B90.9

ICD-10 Finland

Sequelae of respiratory and unspecified tuberculosis

+∞

21.9

SPAT1131

SPAT

Colonoscopy

3.9

21.8

244

N06AX11

ATC

mirtazapine; oral

1.7

21.8

561

3694

E000002

ATC

2.2

21.5

241

1178

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.1

21.4

256

1287

M01AE02

ATC

naproxen; oral, rectal

1.5

21.4

1080

8432

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

9.3

21.3

M03BX02

ATC

tizanidine; oral

1.5

21.2

1109

8726

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.7

21.1

501

3217

SPAT1149

SPAT

Suture or treatment of traumatic wound

2.2

21.0

239

1173

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

13.5

21.0

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

21.0

321

1781

-1

NOMESCO Finland

1.6

20.9

675

4713

4931B

ICD-9 Finland

Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]

+∞

20.9

S15

ICPC

Foreign body in skin

2.7

20.6

145

555

A46

ICD-10 Finland

Erysipelas

2.2

20.5

227

1104

R03BB07

ATC

umeclidinium bromide; inhalant

25.7

20.4

M25.5

ICD-10 Finland

Pain in joint

1.7

20.3

500

3235

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

20.3

640

4434

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

4.9

20.3

140

4779A

ICD-9 Finland

Allergic rhinitis, Cause unspecified

15.2

20.2

R03AC18

ATC

indacaterol; inhalant

32.8

20.2

E000001

ATC

1.8

20.1

396

2393

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

4.5

20.1

160

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

58.0

19.9

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

19.8

1000

7756

N06AA09

ATC

amitriptyline; systemic

2.3

19.8

186

834

GX1L5

NOMESCO Finland

Exhaled nitric oxide analysis

+∞

19.8

C03DA01

ATC

spironolactone; oral

2.4

19.8

183

815

SPAT1130

SPAT

Esophagoscopy, gastroscopy and duodenoscopy

4.0

19.8

205

J10.1

ICD-10 Finland

Influenza with other respiratory manifestations, seasonal influenza virus identified

74.1

19.7

D07AC13

ATC

mometasone; topical

1.7

19.6

534

3554

R29

ICPC

Respiratory symptom/complaint other

3.0

19.6

118

411

XW5WT

NOMESCO Finland

Other blood specimen with radiologicl guidance

105.9

19.6

R1250

NOMESCO Finland

Evaluation of functional capability

4.9

19.5

133

N06AX16

ATC

venlafaxine; oral

2.0

19.5

250

1293

S01GX02

ATC

levocabastine; ophthalmic

2.7

19.3

137

527

J35.1

ICD-10 Finland

Hypertrophy of tonsils

46.4

19.2

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.9

19.1

310

1754

SPAT1216

SPAT

Assessment of functional ability

1.9

19.1

286

1571

R05CA10

ATC

expectorants - combinations

4.6

19.0

146

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

4.3

19.0

169

R74

ICPC

Upper respiratory infection acute

1.7

18.9

514

3411

P01AB01

ATC

metronidazole; oral, rectal

1.6

18.9

707

5099

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.3

18.8

182

828

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

18.8

R42

ICD-10 Finland

Dizziness and giddiness

1.8

18.7

382

2332

E66.9

ICD-10 Finland

Obesity, unspecified

4.5

18.6

154

M05BA04

ATC

alendronic acid; oral

2.5

18.5

149

618

R53

ICD-10 Finland

Malaise and fatigue

1.8

18.2

357

2148

H66.9

ICD-10 Finland

Otitis media, unspecified

2.7

18.2

124

468

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.4

18.2

153

J43.9

ICD-10 Finland

Emphysema, unspecified

33.1

18.0

N02AA05

ATC

oxycodone; systemic

2.1

17.9

224

1145

R49.08

ICD-10 Finland

Other specified dysphonia

6.4

17.9

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

7.7

17.8

N05BB01

ATC

hydroxyzine; systemic

2.6

17.8

135

542

D86.8

ICD-10 Finland

Sarcoidosis of other and combined sites

+∞

17.7

J93.1

ICD-10 Finland

Other spontaneous pneumothorax

+∞

17.7

J98.0

ICD-10 Finland

Diseases of bronchus, not elsewhere classified

+∞

17.7

132

Kela drug reimbursment

Sarcoidosis

+∞

17.7

4912A

ICD-9 Finland

Chronic bronchitis, Obstructive chronic bronchitis[BRONCHITIS CHRONICA OBSTRUCTIVA]

+∞

17.7

Z00.8

ICD-10 Finland

Other general examinations

2.4

17.6

153

661

H66.0

ICD-10 Finland

Acute suppurative otitis media

2.5

17.6

140

576

R07.3

ICD-10 Finland

Other chest pain

2.3

17.2

162

730

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

8.5

17.2

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

7.0

17.2

H02AB09

ATC

hydrocortisone; systemic

4.8

17.2

121

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

17.1

880

6781

D07AA02

ATC

hydrocortisone; topical

1.9

17.0

275

1549

AN1

Coronary angiography

2.1

17.0

203

1018

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

16.9

197

975

E66.8

ICD-10 Finland

Other obesity

3.1

16.9

321

C08DA01

ATC

verapamil; systemic

3.2

16.9

295

R05CB01

ATC

acetylcysteine; inhalant, oral

7.5

16.7

8070/3-C34.9

ICD-O-3

Squamous cell carcinoma, NOS, of lung, NOS

+∞

16.7

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

+∞

16.7

J35.3

ICD-10 Finland

Hypertrophy of tonsils with hypertrophy of adenoids

+∞

16.7

J42

ICD-10 Finland

Unspecified chronic bronchitis

16.4

16.5

D07AC01

ATC

betamethasone; topical

1.6

16.5

592

4203

GD1AD

NOMESCO Finland

Thorax CT examination

4.6

16.4

127

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

9.5

16.4

N06AB03

ATC

fluoxetine; oral

2.0

16.3

224

1187

N05BA01

ATC

diazepam; systemic, rectal

1.9

16.2

235

1273

M01AE03

ATC

ketoprofen; systemic, rectal

1.5

16.1

638

4628

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

16.1

513

3534

Z51.0

ICD-10 Finland

Radiotherapy session

6.1

16.0

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.6

16.0

506

3475

D07AB02

ATC

hydrocortisone butyrate; topical

1.6

15.9

499

3420

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

15.9

217

1149

R52.2

ICD-10 Finland

Other chronic pain

3.6

15.8

201

L03

ICPC

Low back symptom/complaint

1.6

15.8

420

2759

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

3.7

15.7

191

SPAT1301

SPAT

No procedures

1.5

15.7

593

4247

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

15.7

749

5651

M48.0

ICD-10 Finland

Spinal stenosis

2.0

15.6

201

1038

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

+∞

15.6

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.5

15.5

214

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.3

15.5

152

696

SPAT1240

SPAT

Therapeutic discussion

2.0

15.4

205

1071

R03DA54

ATC

theophylline, combinations excl. psycholeptics; systemic

7.3

15.2

J01DA08

ATC

[U] cefaclor; oral

1.9

15.2

239

1332

RP210

NOMESCO Finland

28.8

15.2

N06AB04

ATC

citalopram; systemic

1.7

15.2

359

2276

XX2XT

NOMESCO Finland

Other injection with other radiological guidance

17.8

15.1

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

4.2

15.0

139

M01AH02

ATC

rofecoxib; oral

1.9

15.0

220

1195

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

15.0

216

1168

G43.9

ICD-10 Finland

Migraine, unspecified

2.7

14.9

104

398

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.6

14.9

459

3126

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.8

14.8

369

J18.1

ICD-10 Finland

Lobar pneumonia, unspecified

31.9

14.8

N05AH04

ATC

quetiapine; oral

1.8

14.7

273

1607

H65.3

ICD-10 Finland

Chronic mucoid otitis media

4.8

14.7

101

N05CD07

ATC

temazepam; oral

1.9

14.7

219

1197

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

14.6

166

816

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

14.6

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

14.6

4859X

ICD-9 Finland

Bronchopneumonia, organism unspecified[PNEUMONIA NUD]

3.9

14.6

153

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

80.6

14.6

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

14.5

697

5247

A03

ICPC

Fever

1.8

14.5

273

1613

R49.01

ICD-10 Finland

Functional dysphonia

4.1

14.5

139

R52.9

ICD-10 Finland

Pain, unspecified

2.2

14.5

148

693

SPAT1360

SPAT

Extensive global examination

2.2

14.5

150

705

R03AC19

ATC

olodaterol; inhalant

150.8

14.5

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

14.4

279

1663

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

3.3

14.4

227

M01AH05

ATC

etoricoxib; oral

1.4

14.4

1015

8239

XA402

NOMESCO Finland

ENMG

3.7

14.3

166

SPAT1097

SPAT

Recording of ECG

1.8

14.1

244

1403

XG430

NOMESCO Finland

Spiroegometry

42.7

14.1

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

42.7

14.1

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.9

14.0

232

1314

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

2.8

14.0

318

UDQ02

NOMESCO Finland

Direct laryngoscopy

15.9

13.9

R03DA05

ATC

aminophylline; systemic, rectal

15.9

13.9

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.8

13.9

276

1659

SPAT1273

SPAT

Structured assessment of psychoactive substance / tobacco use

2.7

13.9

354

A41.9

ICD-10 Finland

Sepsis, unspecified

3.7

13.9

165

O99.5

ICD-10 Finland

Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium

30.2

13.9

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

13.9

236

1349

I45.9

ICD-10 Finland

Conduction disorder, unspecified

11.5

13.8

SPAT1260

SPAT

Consultation of another employee

1.7

13.8

307

1913

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

2.2

13.6

143

679

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.9

13.6

195

1048

J18.0

ICD-10 Finland

Bronchopneumonia, unspecified

75.5

13.6

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.2

13.6

134

616

8000/3-C34.9

ICD-O-3

Neoplasm, malignant of lung, NOS

+∞

13.5

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

13.5

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

13.5

1350A

ICD-9 Finland

Sarcoidosis[SARCOIDOSIS]

+∞

13.5

D86.1

ICD-10 Finland

Sarcoidosis of lymph nodes

+∞

13.5

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.2

13.5

136

632

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.0

13.5

174

900

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

13.4

415

2820

J11.1

ICD-10 Finland

Influenza with other respiratory manifestations, virus not identified

5.9

13.4

J30.0

ICD-10 Finland

Vasomotor rhinitis

5.7

13.4

J01DC02

ATC

cefuroxime; systemic

2.6

13.3

387

R06AX11

ATC

astemizole; oral

3.1

13.3

242

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

13.2

358

2349

M04AA01

ATC

allopurinol; systemic

1.9

13.2

198

1082

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

13.2

1317

11304

R83

ICPC

Respiratory infection other

1.6

13.2

440

3046

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.6

13.2

346

2255

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

15.1

13.1

J04.0

ICD-10 Finland

Acute laryngitis

3.9

13.0

134

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

5.8

13.0

R03AL04

ATC

indacaterol and glycopyrronium bromide; inhalant

28.5

13.0

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

12.9

324

2084

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.4

12.9

106

447

E66.00

ICD-10 Finland

Metabolic syndrome

2.8

12.9

310

EMB20

NOMESCO Finland

Adenotonsillectomy

22.6

12.9

A03FA02

ATC

cisapride; oral, rectal

2.1

12.8

141

682

SPAT1153

SPAT

Removal of sutures

1.5

12.8

544

3974

R28

ICPC

Limited function/disability (R)

8.5

12.7

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

12.7

347

2284

A06AD11

ATC

lactulose; oral

1.8

12.7

235

1382

J33.9

ICD-10 Finland

Nasal polyp, unspecified

12.3

12.6

J92.9

ICD-10 Finland

Pleural plaque without asbestos

70.2

12.6

J21.90

ICD-10 Finland

Acute obstructive bronchitis in children

70.2

12.6

49099

ICD-8 Finland

Bronchitis, unspecified

7.9

12.6

GD1AA

SPAT

2.3

12.6

112

492

GX1E5

NOMESCO Finland

Flow volume spirometry and bronchodilation test

32.2

12.6

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.6

12.6

357

2373

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.0

12.5

157

804

J20.5

ICD-10 Finland

Acute bronchitis due to respiratory syncytial virus

+∞

12.5

348

Kela drug reimbursment

Roflumilast

+∞

12.5

49104

ICD-8 Finland

Chronic bronchitis, Cum emphysemate

+∞

12.5

RF421

NOMESCO Finland

10.1

12.5

D86.9

ICD-10 Finland

Sarcoidosis, unspecified

130.6

12.4

J94.8

ICD-10 Finland

Other specified pleural conditions

130.6

12.4

PLAK0

NOMESCO Finland

6.1

12.4

D07CC01

ATC

betamethasone and antibiotics; topical

1.8

12.4

220

1277

RF430

NOMESCO Finland

11.7

12.3

GD5AD

NOMESCO Finland

Thorax and upper abdomen combined CT examination of

11.7

12.3

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

12.2

256

1564

S01GX08

ATC

ketotifen; ophthalmic

3.0

12.2

245

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.8

12.1

275

M79.7

ICD-10 Finland

Fibromyalgia

3.4

12.1

175

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

2.3

12.0

111

496

R06AX12

ATC

terfenadine; oral

2.6

12.0

325

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

12.0

374

2544

317

Kela drug reimbursment

Topical pimecrolimus and tacrolimus

5.2

12.0

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

4.2

11.9

106

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

11.9

256

1574

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.4

11.8

732

5737

B01AA03

ATC

warfarin; systemic

1.6

11.8

311

2024

N06AB10

ATC

escitalopram; oral

1.6

11.7

328

2167

R07

ICPC

Sneezing/nasal congestion

2.2

11.7

115

531

Angiography of the heart and coronary arteries

2.3

11.7

112

511

I25.0

ICD-10 Finland

Atherosclerotic cardiovascular disease, so described

2.3

11.7

103

450

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

11.6

118

551

RJ190

NOMESCO Finland

23.0

11.6

J05AH02

ATC

oseltamivir; oral

11.1

11.5

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

11.5

J84.8

ICD-10 Finland

Other specified interstitial pulmonary diseases

+∞

11.5

4939B

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA CUM EXACERBATIONE]

+∞

11.5

R09

ICPC

Sinus symptom/complaint

2.2

11.5

117

547

J13

ICD-10 Finland

Pneumonia due to Streptococcus pneumoniae

120.5

11.4

J38.2

ICD-10 Finland

Nodules of vocal cords

120.5

11.4

J98.1

ICD-10 Finland

Pulmonary collapse

120.5

11.4

I20.00

ICD-10 Finland

Unstable angina

3.1

11.4

205

I50.1

ICD-10 Finland

Left ventricular failure

2.7

11.4

287

N06AX03

ATC

mianserin; oral

2.6

11.3

312

WX308

NOMESCO Finland

Sacral anesthesy

11.8

11.3

UGC18

NOMESCO Finland

Flexible bronchoscopy with biopsy of lung

35.2

11.3

N06AA12

ATC

doxepin; systemic

2.4

11.2

400

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

2.0

11.0

142

736

ZXC60

NOMESCO Finland

Application of heat

10.1

11.0

Z50.5

ICD-10 Finland

Speech therapy

4.6

11.0

M05BA07

ATC

risedronic acid; oral

3.1

10.9

189

L50.0

ICD-10 Finland

Allergic urticaria

3.4

10.9

151

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.9

10.9

223

A02BA04

ATC

nizatidine; systemic

2.0

10.9

130

655

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.6

10.8

339

2303

50708

ICD-8 Finland

Hay fever, Alia definita

12.0

10.8

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

2.7

10.8

271

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.3

10.8

427

K05

ICPC

Irregular heartbeat other

2.9

10.8

231

4226

FHL

Posterior radical surgery and possible etmoidectomy

10.6

10.8

DPA30

NOMESCO Finland

Sphenotomy

28.1

10.7

RD210

NOMESCO Finland

4.1

10.7

C10AA01

ATC

simvastatin; oral

1.4

10.7

699

5513

M01AC06

ATC

meloxicam; systemic, rectal

1.4

10.7

600

4606

L27.2

ICD-10 Finland

Dermatitis due to ingested food

7.6

10.7

4222

FHL

Endonasal etmoidectomy

12.9

10.6

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

4.2

10.6

WW200

NOMESCO Finland

Immunization

3.5

10.6

144

G44.2

ICD-10 Finland

Tension-type headache

1.7

10.6

205

1222

J01.4

ICD-10 Finland

Acute pansinusitis

60.2

10.6

J32.1

ICD-10 Finland

Chronic frontal sinusitis

60.2

10.6

C09CA01

ATC

losartan; oral

1.5

10.6

371

2585

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

10.6

119

584

C08CA01

ATC

amlodipine; oral

1.4

10.6

550

4159

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

4.3

10.6

XA420

NOMESCO Finland

Extensive sleep examination

7.0

10.5

N03AE01

ATC

clonazepam; systemic

2.4

10.5

388

WX722

NOMESCO Finland

PEEP

2.9

10.5

217

S22.3

ICD-10 Finland

Fracture of rib

2.2

10.5

103

473

XQ848

NOMESCO Finland

Dermatological photography

3.0

10.5

204

Z72.0

ICD-10 Finland

Tobacco use

4.1

10.5

100

H25.1

ICD-10 Finland

Senile nuclear cataract

1.5

10.5

405

2884

UJF32

NOMESCO Finland

Coloscopy

1.5

10.5

394

2789

X58

ICD-10 Finland

Exposure to other specified factors

1.7

10.4

218

1329

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.7

10.4

257

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

110.4

10.4

C34.3

ICD-10 Finland

Malignant neoplasm: Lower lobe, bronchus or lung

110.4

10.4

J38.3

ICD-10 Finland

Other diseases of vocal cords

110.4

10.4

R03DX07

ATC

roflumilast; oral

+∞

10.4

J38.4

ICD-10 Finland

Oedema of larynx

+∞

10.4

4939A

ICD-9 Finland

Asthma, unspecified[ASTHMA ALIA DEFINITA SINE EXACERBATIONE]

+∞

10.4

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.7

10.4

198

1176

C08CA13

ATC

lercanidipine; oral

1.7

10.4

209

1262

EBA00

NOMESCO Finland

Extraction of tooth

1.4

10.3

592

4552

I45.8

ICD-10 Finland

Other specified conduction disorders

10.6

10.3

R39

ICPC

Respiratory, Physical function test

10.6

10.3

N04BC05

ATC

pramipexole; oral

2.1

10.2

112

544

J41.0

ICD-10 Finland

Simple chronic bronchitis

23.4

10.2

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

3.2

10.2

160

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

2.0

10.2

133

694

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

10.2

469

3461

R1410

NOMESCO Finland

Drawing up a rehabilitation plan

13.2

10.1

H57.1

ICD-10 Finland

Ocular pain

3.1

10.1

183

R21

NOMESCO Finland

Counselling and guidance in rehabilitation

5.7

10.1

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

6.9

10.1

DFF00

NOMESCO Finland

Pure tone audiometry

1.9

10.1

146

791

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

10.1

112

545

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.8

10.0

181

1057

D02AE01

ATC

carbamide; topical

2.0

10.0

121

612

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

10.1

10.0

TQW80

NOMESCO Finland

Local dermatologic skincare

3.1

10.0

168

C01AA05

ATC

digoxin; systemic

2.0

10.0

133

696

E000006

ATC

2.0

10.0

127

655

GDC00

NOMESCO Finland

Lobectomy of lung

40.2

10.0

RF220

NOMESCO Finland

4.1

9.9

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.3

9.9

407

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.6

9.9

252

1627

RF313

NOMESCO Finland

12.2

9.8

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

9.8

703

5610

M09AA72

ATC

quinine, combinations with psycholeptics; systemic

2.6

9.8

275

KHV

NOMESCO Finland

5.4

9.8

4660A

ICD-9 Finland

Acute bronchitis and bronchiolitis, Acute bronchitis

5.7

9.8

H65.1

ICD-10 Finland

Other acute nonsuppurative otitis media

5.7

9.8

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

2.4

9.8

359

R01AC02

ATC

levocabastine; nasal

3.1

9.8

171

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

3.1

9.8

171

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

9.8

211

D07BC01

ATC

betamethasone and antiseptics; topical

1.7

9.7

205

1254

M79.1

ICD-10 Finland

Myalgia

1.7

9.7

198

1198

SPAT1098

SPAT

Exercise ECG

3.4

9.7

139

K30

ICD-10 Finland

Functional dyspepsia

1.8

9.7

165

946

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

2.9

9.7

194

J01EA01

ATC

trimethoprim; systemic

1.4

9.7

438

3216

C08DB01

ATC

diltiazem; oral

2.2

9.6

442

A03FA01

ATC

metoclopramide; systemic, rectal

1.5

9.6

309

2113

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.9

9.5

142

778

E000003

ATC

2.4

9.5

350

UDC00

NOMESCO Finland

Ear microscopy

2.1

9.5

108

532

M70.6

ICD-10 Finland

Trochanteric bursitis

1.8

9.5

177

1043

S97

ICPC

Chronic ulcer skin

2.5

9.4

306

T78.2

ICD-10 Finland

Anaphylactic shock, unspecified

6.6

9.4

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.7

9.4

182

1086

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

9.4

954

8026

RF310

NOMESCO Finland

17.6

9.4

49109

ICD-8 Finland

Chronic bronchitis, Unspecified

+∞

9.4

C34.99

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology

+∞

9.4

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.9

9.3

140

767

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

9.3

279

1872

QDB10

NOMESCO Finland

Major dressing of wound of skin of lower limb

2.5

9.3

301

B01AC04

ATC

clopidogrel; oral

1.6

9.3

231

1478

PLAK1

NOMESCO Finland

4.0

9.3

R03AL03

ATC

vilanterol and umeclidinium bromide; inhalant

8.7

9.3

4610A

ICD-9 Finland

Acute sinusitis, Maxillary

4.3

9.3

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

9.3

381

2744

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.9

9.3

126

669

M13.9

ICD-10 Finland

Arthritis, unspecified

2.1

9.2

106

524

SPAT1081

SPAT

Cardiorespiratory global assessment

2.2

9.2

408

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

9.2

258

1704

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

9.1

116

598

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.5

9.0

339

2392

K59.09

ICD-10 Finland

Constipation, unspecified

2.2

9.0

404

H01

ICPC

Ear pain/earache

1.7

9.0

185

1122

J15.8

ICD-10 Finland

Other bacterial pneumonia

36.8

9.0

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

9.0

280

1897

A02BX02

ATC

sucralfate; oral

2.4

8.9

296

R03AC04

ATC

fenoterol; inhalant

18.7

8.9

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

2.0

8.9

115

598

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

2.3

8.9

337

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.5

8.9

261

RJ421

NOMESCO Finland

12.6

8.9

R94.2

ICD-10 Finland

Abnormal results of pulmonary function studies

12.6

8.9

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

8.8

185

1129

4224

FHL

Endonasal anthrostomy

6.8

8.8

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

8.8

319

N07BA03

ATC

varenicline; oral

2.4

8.8

311

WZA10

NOMESCO Finland

Long statement of health and health related matters

5.0

8.8

RF212

NOMESCO Finland

10.7

8.8

RJ410

NOMESCO Finland

10.7

8.8

Z25.8

ICD-10 Finland

Need for immunization against other specified single viral diseases

1.6

8.8

218

1398

M10.9

ICD-10 Finland

Gout, unspecified

2.2

8.8

431

SPAT1255

SPAT

Intravenous administration of medicine

2.1

8.8

441

D11AH01

ATC

tacrolimus; topical

5.9

8.7

G04CA02

ATC

tamsulosin; oral

1.5

8.7

339

2410

R01AX03

ATC

ipratropium bromide; nasal

3.4

8.7

119

J12.9

ICD-10 Finland

Viral pneumonia, unspecified

50.1

8.7

V01AA02

ATC

grass pollen; systemic

50.1

8.7

M02AA07

ATC

piroxicam; topical

1.4

8.7

592

4672

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

3.1

8.7

152

R05CB02

ATC

bromhexine; systemic

4.1

8.6

Z20.9

ICD-10 Finland

Contact with and exposure to unspecified communicable disease

2.7

8.6

210

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

4.2

8.6

ZX114

NOMESCO Finland

Intramuscular

4.2

8.6

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.5

8.6

264

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.8

8.5

148

852

XF600

NOMESCO Finland

Bloodpressure measurement

2.1

8.5

453

E11.00

ICD-10 Finland

Non-insulin dependent diabetes diabetic hypoglycaemic coma

2.8

8.5

198

GAA10

NOMESCO Finland

Intercostal insertion of pleural drainage tube

6.9

8.5

46699

ICD-8 Finland

Acute bronchitis and bronchiolitis

4.4

8.5

L28

ICPC

Limited function/disability (L)

1.6

8.5

229

1497

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.3

8.5

121

E000007

ATC

2.0

8.5

496

RJ511

NOMESCO Finland

27.6

8.5

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

90.3

8.4

E88.0

ICD-10 Finland

Disorders of plasma-protein metabolism, not elsewhere classified

90.3

8.4

J38.1

ICD-10 Finland

Polyp of vocal cord and larynx

90.3

8.4

J96.9

ICD-10 Finland

Respiratory failure, unspecified

90.3

8.4

R03AL05

ATC

formoterol and aclidinium bromide; inhalant

90.3

8.4

J61

ICD-10 Finland

Pneumoconiosis due to asbestos and other mineral fibres

90.3

8.4

R55

ICD-10 Finland

Syncope and collapse

1.7

8.4

164

980

RJ411

NOMESCO Finland

7.9

8.4

M10.0

ICD-10 Finland

Idiopathic gout

2.8

8.3

179

R4110

SPAT

2.7

8.3

209

J21.0

ICD-10 Finland

Acute bronchiolitis due to respiratory syncytial virus

+∞

8.3

49308

ICD-8 Finland

Asthma, Alia definita

+∞

8.3

4940A

ICD-9 Finland

Bronchiectasis[BRONCHIECTASIAE]

+∞

8.3

51899

ICD-8 Finland

Bronchiectasis

+∞

8.3

R2110

NOMESCO Finland

Giving the first information

1.9

8.3

120

649

G43.3

ICD-10 Finland

Complicated migraine

4.3

8.3

F03

ICPC

Eye discharge

2.0

8.3

104

536

M02AA10

ATC

ketoprofen; topical

1.5

8.3

250

1680

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

2.4

8.3

284

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

8.2

154

908

R21

ICPC

Throat symptom/complaint

1.5

8.2

337

2419

D07AB08

ATC

desonide; topical

1.7

8.2

171

1045

N39.3

ICD-10 Finland

Stress incontinence

1.9

8.2

113

601

Z08

ICPC

Social welfare problem

4.9

8.2

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

8.2

159

952

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

8.1

143

829

I20.09

ICD-10 Finland

Unstable angina

2.1

8.1

407

S80.0

ICD-10 Finland

Contusion of knee

1.9

8.1

107

563

I20.89

ICD-10 Finland

Other angina pectoris unspecified coronary artery status

2.4

8.1

288

S01ED02

ATC

betaxolol; ophthalmic

4.7

8.1

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.7

8.1

194

R03BB05

ATC

aclidinium bromide; inhalant

33.4

8.1

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

33.4

8.1

J41.1

ICD-10 Finland

Mucopurulent chronic bronchitis

33.4

8.1

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

1.8

8.1

135

770

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

8.1

100

513

ZX100

NOMESCO Finland

Oral

4.0

8.0

69100

ICD-8 Finland

Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum

4.5

8.0

S87

ICPC

Dermatitis/atopic eczema

2.9

8.0

158

L04AX01

ATC

azathioprine; systemic

2.5

8.0

245

B37.08

ICD-10 Finland

Other candidal stomatitis

10.1

8.0

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.4

8.0

264

SPAT1211

SPAT

Application of soft bandage

1.7

8.0

149

881

N06BA04

ATC

methylphenidate; oral

3.1

8.0

133

L29.9

ICD-10 Finland

Pruritus, unspecified

3.2

8.0

122

S06.0

ICD-10 Finland

Concussion

1.7

8.0

165

1004

R06AX18

ATC

acrivastine; oral

2.9

8.0

160

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.7

8.0

170

1044

QDB05

NOMESCO Finland

Revision of wound of skin of lower limb

3.5

8.0

101

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

7.9

148

876

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

1.7

7.9

161

975

N18.8

ICD-10 Finland

Other chronic renal failure

3.0

7.9

154

R03BA07

ATC

mometasone; inhalant

6.6

7.9

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.8

7.9

142

830

L97

ICD-10 Finland

Ulcer of lower limb, not elsewhere classified

2.8

7.8

175

R04

ICPC

Breathing problem other

2.7

7.8

185

R1240

NOMESCO Finland

Social assessment of need and possibilities of rehabilitation

5.4

7.8

H92.0

ICD-10 Finland

Otalgia

2.1

7.8

401

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.9

7.8

110

590

Z97.4

ICD-10 Finland

Presence of external hearing-aid

2.1

7.8

391

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.8

7.8

133

765

J11.8

ICD-10 Finland

Influenza with other manifestations, virus not identified

8.5

7.8

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.6

7.8

206

1339

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

7.8

363

2675

C09CA06

ATC

candesartan; oral

1.5

7.8

326

2353

Y0499

ICD-8 Finland

Investigation of respiratory system

4.8

7.7

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.5

7.7

230

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

7.7

199

1288

XJH00

NOMESCO Finland

Transanal ultrasonography

1.9

7.7

101

530

N03AX09

ATC

lamotrigine; oral

2.3

7.7

320

V01AA05

ATC

tree pollen; parenteral

7.4

7.7

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

7.7

197

1271

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.6

7.7

214

1414

N05BA12

ATC

alprazolam; oral

1.7

7.7

149

893

Z71.9

ICD-10 Finland

Counselling, unspecified

2.0

7.6

465

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

2.6

7.6

207

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

2.1

7.6

390

A92

ICPC

Allergy/allergic reaction NOS

2.8

7.6

160

M54.0

ICD-10 Finland

Panniculitis affecting regions of neck and back

4.2

7.6

A28

ICPC

Limited function/disability NOS

1.6

7.6

213

1409

ZX108

NOMESCO Finland

Inhalation

11.9

7.6

J18.8

ICD-10 Finland

Other pneumonia, organism unspecified

25.1

7.6

G47.9

ICD-10 Finland

Sleep disorder, unspecified

3.0

7.6

133

L01

ICPC

Neck symptom/complaint

1.6

7.5

214

1416

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.2

7.5

350

J30.19

ICD-10 Finland

Pollen allergy UNS

2.7

7.5

178

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

7.5

218

1451

M47.9

ICD-10 Finland

Spondylosis, unspecified

2.7

7.5

186

KMAK

NOMESCO Finland

1.3

7.5

890

7581

AN2

Balloon angioplasty, including several vessels

2.6

7.5

204

48509

ICD-8 Finland

Bronchopneumonia, unspecified

4.8

7.4

P29

ICPC

Psychological sympt/compl other

2.0

7.4

479

H03AA01

ATC

levothyroxine sodium; systemic

1.4

7.4

370

2759

TGD04

NOMESCO Finland

Needle biopsy of the lungs in bronchoscopy

80.3

7.4

4719X

ICD-9 Finland

Nasal polyps, Unspecified nasal polyp

80.3

7.4

3023

Kela drug reimbursment

Allergen extract of birch pollen (adults)

80.3

7.4

J93.9

ICD-10 Finland

Pneumothorax, unspecified

80.3

7.4

R01AD

ATC

Corticosteroids

5.0

7.4

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

2.1

7.4

380

R03DB04

ATC

theophylline and adrenergics; systemic

13.4

7.4

R01BA01

ATC

phenylpropanolamine; oral

2.0

7.4

431

SPAT1283

SPAT

Restricted health certificate

1.5

7.4

294

2097

F60.5

ICD-10 Finland

Anankastic personality disorder

5.3

7.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

7.4

458

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.0

7.4

483

J05AB01

ATC

aciclovir; systemic

1.4

7.4

330

2412

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

7.3

395

M41.9

ICD-10 Finland

Scoliosis, unspecified

3.9

7.3

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.9

7.3

103

556

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

1.9

7.3

106

575

WZC30

SPAT

3.0

7.3

131

R03CC03

ATC

terbutaline; systemic

2.7

7.3

176

J82

ICD-10 Finland

Pulmonary eosinophilia, not elsewhere classified

+∞

7.3

C34.16

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma

+∞

7.3

DPW99

NOMESCO Finland

Other operation on frontal or sphenoidal sinus

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

A16.0

ICD-10 Finland

Tuberculosis of lung, bacteriologically and histologically negative

+∞

7.3

XG488

NOMESCO Finland

Other provokation of respiratroy tract

+∞

7.3

DMB10

NOMESCO Finland

Radical maxillary antrotomy

+∞

7.3

J98.6

ICD-10 Finland

Disorders of diaphragm

+∞

7.3

E66.0

ICD-10 Finland

Obesity due to excess calories

4.9

7.3

K59.0

ICD-10 Finland

Constipation

2.0

7.3

450

DFF15

NOMESCO Finland

Speech audiometry

2.2

7.3

339

R69

ICD-10 Finland

Unknown and unspecified causes of morbidity

3.2

7.2

115

J20.0

ICD-10 Finland

Acute bronchitis due to Mycoplasma pneumoniae

15.8

7.2

205

Kela drug reimbursment

Chronic hypertension

1.4

7.2

448

3466

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.3

7.2

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

3.0

7.2

127

R39.1

ICD-10 Finland

Other difficulties with micturition

2.7

7.2

179

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

2.7

7.1

172

S93.2

ICD-10 Finland

Rupture of ligaments at ankle and foot level

3.7

7.1

R11

ICD-10 Finland

Nausea and vomiting

1.8

7.1

118

673

P01

ICPC

Feeling anxious/nervous/tense

1.6

7.1

176

1128

ZX140

NOMESCO Finland

Intra articular

5.0

7.1

Z01.3

ICD-10 Finland

Examination of blood pressure

4.2

7.1

R01

ICPC

Pain respiratory system

4.2

7.1

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

3.1

7.1

117

A02BC04

ATC

rabeprazole; oral

1.8

7.1

119

682

C07AB05

ATC

betaxolol; oral

2.4

7.0

225

A10BA02

ATC

metformin; oral

1.4

7.0

417

3201

SGA01

NOMESCO Finland

Tooth opening as first aid

1.5

7.0

240

1660

A10BJ06

ATC

semaglutide; parenteral

2.5

7.0

200

J03.0

ICD-10 Finland

Streptococcal tonsillitis

2.9

7.0

138

D07AD01

ATC

clobetasol; topical

1.5

7.0

241

1671

SPAT1236

SPAT

Informing family of child’s disability

2.8

7.0

146

K10.3

ICD-10 Finland

Alveolitis of jaws

2.1

7.0

332

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

2.3

7.0

269

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

6.9

165

1047

A11CC03

ATC

alfacalcidol; systemic

3.2

6.9

108

50301

ICD-8 Finland

Chronic sinusitis, Maxillaris NUD

5.5

6.9

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.6

6.9

163

1032

M01AX17

ATC

nimesulide; oral

1.4

6.9

365

2746

J00

ICD-10 Finland

Acute nasopharyngitis [common cold]

3.5

6.9

Z50.1

ICD-10 Finland

Other physical therapy

2.0

6.9

401

A10BX04

ATC

[U] exenatide; parenteral

4.8

6.8

G56.2

ICD-10 Finland

Lesion of ulnar nerve

2.6

6.8

179

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.9

6.8

100

546

M05BB03

ATC

alendronic acid and colecalciferol; oral

2.9

6.8

135

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

2.3

6.8

275

4239

FHL

Other measure in this category

11.0

6.8

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

2.1

6.8

369

UDQ22

NOMESCO Finland

Microlaryngoscopy

9.3

6.8

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

9.3

6.8

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.2

6.8

300

A31.0

ICD-10 Finland

Pulmonary mycobacterial infection

40.1

6.8

U01

ICPC

Dysuria/painful urination

1.7

6.8

122

717

R05DB20

ATC

other cough suppressants - combinations

1.9

6.7

464

Z01.2

ICD-10 Finland

Dental examination

1.3

6.7

708

5913

N30.0

ICD-10 Finland

Acute cystitis

1.5

6.7

212

1440

XKD00

NOMESCO Finland

Uroflowmetry

1.5

6.7

225

1551

T82

ICPC

Obesity

2.4

6.7

219

R03DA74

ATC

theophylline, combinations with psycholeptics; systemic

22.6

6.7

RK322

NOMESCO Finland

22.6

6.7

R13

ICD-10 Finland

Dysphagia

2.0

6.7

443

R06AE08

ATC

4.9

6.7

C03EB01

ATC

furosemide and potassium-sparing agents; systemic

2.1

6.6

330

B02AA02

ATC

tranexamic acid; systemic

1.5

6.6

224

1546

4221

FHL

Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room

5.2

6.6

L50.9

ICD-10 Finland

Urticaria, unspecified

2.3

6.6

244

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

5.9

6.6

ZXA05

NOMESCO Finland

Left side

1.4

6.6

386

2955

QDE99

NOMESCO Finland

Other excision or repair of lesion of skin of lower limb

4.6

6.6

7080A

ICD-9 Finland

Urticaria, Allergic urticaria

12.3

6.6

4711A

ICD-9 Finland

Nasal polyps, Polypoid sinus degeneration

12.3

6.6

XKX00

NOMESCO Finland

Pelvic floor electromyography

8.7

6.5

N06AX12

ATC

bupropion; oral

1.9

6.5

453

160

Kela drug reimbursment

exenatide

3.2

6.5

102

B34.9

ICD-10 Finland

Viral infection, unspecified

2.6

6.5

165

M03BC51

ATC

orphenadrine, combinations; systemic

1.4

6.5

423

3291

46100

ICD-8 Finland

Acute sinusitis, Maxillaris

3.4

6.5

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.7

6.5

121

717

Z02.7

ICD-10 Finland

Issue of medical certificate

1.9

6.5

500

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

6.5

449

3531

Z51.88

ICD-10 Finland

Other specified medical care

3.1

6.4

103

UJC12

NOMESCO Finland

Flexible oesophagoscopy

5.7

6.4

R10.0

ICD-10 Finland

Acute abdomen

2.5

6.4

192

R5599

NOMESCO Finland

Other rehabilitation service

2.5

6.4

192

J41.8

ICD-10 Finland

Mixed simple and mucopurulent chronic bronchitis

70.0

6.4

SPAT1229

SPAT

Assessment of need for aid

1.8

6.4

112

652

SPAT1324

SPAT

Screening procedure

1.4

6.4

283

2063

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.6

6.4

177

Z29.0

ICD-10 Finland

Isolation

14.3

6.4

R06.4

ICD-10 Finland

Hyperventilation

3.5

6.4

U02

ICPC

Urinary frequency/urgency

1.5

6.3

202

1375

R23

ICPC

Voice symptom/complaint

3.2

6.3

RF122

NOMESCO Finland

8.2

6.3

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

8.2

6.3

B02.9

ICD-10 Finland

Zoster without complication

1.9

6.3

445

QDH05

NOMESCO Finland

Correction of deformity of toe nail

11.0

6.3

M54.1

ICD-10 Finland

Radiculopathy

2.3

6.3

246

RF110

NOMESCO Finland

9.3

6.3

RS221

NOMESCO Finland

4.0

6.3

J12.8

ICD-10 Finland

Other viral pneumonia

+∞

6.2

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

6.2

13599

ICD-8 Finland

Sarcoidosis, Unspecified

+∞

6.2

C34.00

ICD-10 Finland

Malignant tumor of the main bronchus without histology

+∞

6.2

J86.9

ICD-10 Finland

Pyothorax without fistula

+∞

6.2

C34.81

ICD-10 Finland

Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma

+∞

6.2

J12.1

ICD-10 Finland

Respiratory syncytial virus pneumonia

+∞

6.2

C34.92

ICD-10 Finland

Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma

+∞

6.2

F17.20

ICD-10 Finland

Addiction relationship caused by tobacco addiction relationship currently independent

+∞

6.2

DNB10

NOMESCO Finland

Endonasal ethmoidectomy

+∞

6.2

J93.0

ICD-10 Finland

Spontaneous tension pneumothorax

+∞

6.2

8140/3-C34.3

ICD-O-3

Adenocarcinoma, NOS, of lower lobe, lung

+∞

6.2

C34.39

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology

+∞

6.2

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

6.2

R5120

NOMESCO Finland

Preparation of an aid

2.5

6.2

182

GEA00

NOMESCO Finland

Mediastinoscopy

26.7

6.2

SPAT1267

SPAT

Desensitisation

26.7

6.2

R03BB06

ATC

glycopyrronium bromide; inhalant

26.7

6.2

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

2.1

6.2

319

S01GX04

ATC

nedocromil; ophthalmic

3.2

6.2

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

2.5

6.2

183

R07.0

ICD-10 Finland

Pain in throat

1.9

6.2

425

R03

ICPC

Wheezing

5.0

6.2

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

3.8

6.2

M01AG01

ATC

mefenamic acid; oral

2.5

6.2

184

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.6

6.2

159

T91

ICPC

Vitamin/nutritional deficiency

5.3

6.1

C01DA14

ATC

isosorbide mononitrate; oral

1.5

6.1

224

1572

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.9

6.1

488

H10.1

ICD-10 Finland

Acute atopic conjunctivitis

2.7

6.1

142

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.6

6.1

164

1072

H65.2

ICD-10 Finland

Chronic serous otitis media

4.2

6.1

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

6.1

402

J01CE02

ATC

phenoxymethylpenicillin; oral

1.2

6.1

1252

11290

SPAT1043

SPAT

Audiometry

1.6

6.1

168

1107

GD1CD

NOMESCO Finland

Thorax extensive CT-examination

8.6

6.0

N05CF02

ATC

zolpidem; oral

1.4

6.0

246

1764

48609

ICD-8 Finland

Pneumonia, unspecified

3.4

6.0

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3005322) IgE [Units/volume] in Serum or Plasma

337

613

6.21

180.82

1.5

1.1

325.76

193.94

u/ml

0.92

324

562

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

36.09

122.81

1.3

1.0

1.36

—

u/ml

—

(3021440) Promyelocytes/100 leukocytes in Blood

371

1136

3.67

102.04

4.3

3.9

0.05

0.11

0.94

267

(3017181) Myelocytes/100 leukocytes in Blood

378

1177

3.61

101.33

4.3

3.9

0.63

0.74

0.27

291

(3025159) Blasts/100 leukocytes in Blood

359

1081

3.72

101.19

4.3

3.9

0.02

0.47

0.71

234

(3023419) Bacteria identified in Sputum by Culture

23.89

100.27

3.0

1.3

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

44.23

87.25

4.3

2.7

—

(3002179) Metamyelocytes/100 leukocytes in Blood

337

1077

3.47

86.13

3.9

3.7

0.41

0.51

0.28

213

(3013115) Eosinophils [#/volume] in Blood

1278

8068

2.21

79.81

6.1

5.2

0.21

0.18

e9/l

8.09

1198

6986

(3022096) Basophils/100 leukocytes in Blood

1150

7029

2.19

77.08

6.0

5.1

0.67

0.69

0.63

1110

6494

(3042631) Mycobacterium sp identified in Specimen

13.26

74.38

3.7

2.1

—

(3006504) Eosinophils/100 leukocytes in Blood

1169

7303

2.14

72.83

6.0

5.1

3.07

2.82

2.38

1126

6731

(3019069) Monocytes/100 leukocytes in Blood

1171

7353

2.13

71.62

6.2

5.3

8.48

8.56

0.44

1131

6827

(3002030) Lymphocytes/100 leukocytes in Blood

1197

7645

2.10

69.25

6.1

5.1

27.55

29.51

8.87

1156

7056

(3001604) Monocytes [#/volume] in Blood

1211

7779

2.09

68.86

5.8

5.0

0.61

0.56

e9/l

13.36

1126

6614

(3018010) Neutrophils/100 leukocytes in Blood

1184

7546

2.09

68.72

5.8

4.9

57.62

56.00

5.12

1144

6996

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

16.47

68.55

1.1

—

(3006315) Basophils [#/volume] in Blood

1214

7815

2.09

68.52

5.9

5.0

0.04

e9/l

3.86

1129

6655

(3019198) Lymphocytes [#/volume] in Blood

1237

8106

2.05

65.55

5.8

5.0

1.94

1.97

e9/l

0.20

1169

7023

(4010399)

224

654

3.67

65.15

1.6

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

113

190

6.18

64.60

1.2

1.0

1.82

1.04

u/ml

0.54

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

102

162

6.52

61.67

3.2

2.2

—

(3000492) Spirometry study

303

1118

2.95

59.90

1.5

1.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

665

3594

2.16

57.54

4.3

3.7

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

100

7.81

54.47

2.0

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

401

1810

2.45

52.75

2.1

1.5

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

111

233

4.94

49.82

1.2

1.1

2.03

1.12

u/ml

0.45

(3023368) Bacteria identified in Blood by Culture

603

3374

2.04

46.17

4.5

3.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

297

1249

2.57

45.06

2.3

2.0

315.64

382.16

nmol/l

7.91

278

1145

(3014133) Dog dander IgE Ab [Units/volume] in Serum

176

5.33

44.83

1.2

1.0

6.95

2.80

u/ml

0.93

(3003888) Timothy IgE Ab [Units/volume] in Serum

100

211

4.90

44.59

1.1

1.0

4.95

5.01

u/ml

0.01

(3021589) Normoblasts [#/volume] in Blood

1114

7703

1.81

44.15

10.9

7.6

0.00

e9/l

1.15

1006

6293

(3013650) Neutrophils [#/volume] in Blood by Automated count

1299

9431

1.80

43.45

8.8

7.4

4.34

3.89

e9/l

11.64

1213

8126

(3008401) Mugwort IgE Ab [Units/volume] in Serum

205

4.78

41.24

1.1

1.0

0.33

2.53

u/ml

1.47

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

874

5780

1.79

38.92

3.7

2.9

30.14

56.80

ng/l

1.75

588

3786

(3015235) Bicarbonate [Moles/volume] in Capillary blood

105

258

4.21

38.71

3.2

2.4

25.00

24.12

mmol/l

1.07

223

(3021901) Oxygen saturation in Capillary blood

171

4.86

36.10

2.3

2.4

—

(3017569) Oxygen content in Arterial blood

8.82

31.93

1.9

1.7

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

150

4.84

31.62

1.1

1.0

0.23

0.22

u/ml

0.03

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

630

4011

1.77

30.57

3.2

2.6

1200.40

1339.79

ng/l

0.41

540

3407

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

135

459

3.05

30.46

2.0

1.2

39.12

38.02

u/l

0.24

125

399

(3023430) Cat dander IgE Ab [Units/volume] in Serum

164

4.56

30.19

1.1

1.0

5.55

4.29

u/ml

0.25

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

258

1217

2.25

29.83

2.2

1.4

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

256

1213

2.24

29.26

2.1

1.4

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

7.86

27.67

2.7

1.8

—

(3016502) Oxygen saturation in Arterial blood

252

1235

2.16

26.41

5.0

6.2

94.90

96.49

3.67

238

1191

(3019060) Gas panel - Arterial blood

173

725

2.49

26.10

3.7

4.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

100

312

3.30

26.05

2.8

3.2

8.45

9.11

kpa

3.07

290

(3041096) Erythrocytes [Presence] in Urine by Automated

699

4758

1.65

25.79

3.5

2.9

—

(3027801) Oxygen [Partial pressure] in Arterial blood

270

1371

2.09

25.78

5.2

5.9

10.94

13.88

kpa

18.32

256

1319

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

270

1372

2.09

25.73

5.2

5.9

5.21

5.00

kpa

2.96

255

1320

(4015189)

17.64

25.53

2.6

1.8

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

707

4839

1.65

25.47

2.8

2.3

52.88

59.25

u/l

4.14

663

4433

(3022217) INR in Platelet poor plasma by Coagulation assay

346

1939

1.91

24.93

17.4

23.2

1.22

1.34

inr

1.00

308

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

176

767

2.39

24.37

3.9

3.0

5.26

5.01

kpa

2.91

162

708

(3009343) pH of Capillary blood

174

757

2.40

24.18

3.9

3.0

7.43

7.42

0.32

(3005719) IgG [Mass/volume] in Serum or Plasma

206

970

2.23

23.80

2.6

2.1

9.75

10.88

g/l

3.61

200

872

(3013707) Erythrocyte sedimentation rate by Westergren method

1555

12901

1.55

23.52

4.8

3.4

12.65

10.92

mm/h

4.95

1494

11857

(42870588) Differential panel, method unspecified - Blood

719

5027

1.61

23.39

6.2

5.1

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1229

9753

1.52

22.34

4.7

3.5

6.43

6.62

mmol/l

3.12

1153

8924

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

500

3224

1.69

22.26

1.9

1.6

0.98

1.23

mg/l

1.50

380

2411

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

163

726

2.33

21.46

3.8

2.9

2.66

1.08

mmol/l

6.46

106

503

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

126

500

2.60

21.29

2.1

1.5

—

(3003396) Base excess in Arterial blood by calculation

257

1374

1.97

21.15

5.3

5.9

1.77

0.48

mmol/l

6.56

203

1047

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

164

742

2.30

20.82

1.8

1.4

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

5.07

20.45

1.7

1.3

6.12

7.42

g/l

1.42

(3024139) IgG subclass 3 [Mass/volume] in Serum

5.07

20.45

1.7

1.3

0.33

0.42

g/l

1.15

(3028192) IgG subclass 2 [Mass/volume] in Serum

5.07

20.45

1.7

1.3

2.54

2.94

g/l

0.95

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

243

1294

1.97

20.20

3.5

3.2

1.23

mmol/l

0.43

227

1092

(4062490)

5.01

20.19

1.9

1.3

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1057

8262

1.49

19.85

5.8

5.0

11.09

12.16

umol/l

1.60

1009

7771

(3008152) Bicarbonate [Moles/volume] in Arterial blood

164

758

2.25

19.79

4.9

5.7

25.50

24.06

mmol/l

4.44

155

699

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

163

3.75

19.34

1.5

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

7.95

19.15

4.2

2.7

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1023

7987

1.48

19.09

6.9

5.1

1.22

mmol/l

0.15

903

6706

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

415

2667

1.67

18.39

1.3

1.2

24.39

31.95

iu/ml

0.81

120

838

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

336

2.80

18.30

2.3

1.6

—

(3037522) Nuclear Ab [Titer] in Serum

325

1957

1.76

18.26

1.5

1.3

392.80

568.79

titre

1.23

396

(3007853) Bacteria identified in Skin by Aerobe culture

285

1657

1.81

18.02

1.9

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

11.25

17.99

1.5

1.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

124

534

2.39

17.63

3.4

3.8

0.76

0.90

3.18

115

500

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

256

3.03

17.49

1.8

1.2

7.88

10.35

mg/l

2.08

233

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

180

906

2.06

17.47

1.5

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

140

3.77

17.01

1.3

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

140

3.77

17.01

1.3

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

5.13

16.94

1.4

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

110

462

2.44

16.54

2.1

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

643

4695

1.50

16.15

4.1

3.5

0.00

estimate

0.69

328

1524

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

121

538

2.31

16.02

3.3

3.8

1.94

1.62

1.02

114

504

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

872

6783

1.44

15.73

3.9

3.4

—

(3044242) Glucose [Moles/volume] in Arterial blood

5.51

15.71

1.5

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

153

3.52

15.67

1.4

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

156

776

2.08

15.63

1.7

1.30

1.38

g/l

0.18

150

699

(3042936) Bacteria identified in Isolate by Culture

306

1897

1.70

15.37

2.2

1.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

909

7170

1.42

15.01

2.5

2.1

77.54

77.27

nmol/l

0.11

857

6478

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

4.48

14.48

1.7

1.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

4.07

14.26

1.4

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

106

3.92

14.23

1.6

1.3

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

364

2.50

14.20

1.6

1.5

105.71

293.68

titre

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

4.68

14.00

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

165

3.26

13.96

1.6

1.3

—

(3026493) Urate [Moles/volume] in Serum or Plasma

554

4062

1.47

13.25

2.7

2.3

3313.10

6831.60

umol/l

1.40

513

3547

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

107

3.78

13.25

1.5

1.2

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1519

13239

1.38

13.15

7.5

5.9

77.00

78.27

u/l

0.65

1465

12348

(40768797) Stomach Pathology biopsy report

324

2120

1.61

13.09

1.2

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

376

2548

1.56

13.08

1.3

1.2

7.46

12.65

u/ml

1.29

206

1052

(3026389) Candida sp identified in Specimen by Organism specific culture

190

2.99

12.80

1.5

1.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

203

1179

1.79

12.80

5.6

6.4

123.22

121.24

g/l

0.62

198

1131

(3024980) IgG subclass 4 [Mass/volume] in Serum

177

3.04

12.46

1.6

1.5

0.62

0.82

g/l

1.09

136

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

345

2.42

12.35

1.4

1.3

—

(3026782) Osmolality of Urine

439

3115

1.50

12.28

3.0

2.4

530.14

556.43

mosm/kgh2o

1.70

387

2586

(3024561) Albumin [Mass/volume] in Serum or Plasma

860

6904

1.38

12.13

4.9

3.9

35.34

36.17

g/l

4.56

809

6379

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

187

1082

1.79

11.94

3.9

2.5

111.95

204.94

ng/l

5.53

166

970

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

6.96

11.85

1.2

1.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

618

4722

1.41

11.61

2.0

1.9

176.01

217.39

u/l

0.74

587

4411

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.30

11.48

1.8

2.1

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

959

7884

1.35

11.46

3.1

2.5

114.57

109.16

ug/l

0.22

911

7309

(1616796) Gas panel - Central venous blood

231

2.68

11.43

2.6

2.8

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

4.06

11.39

1.1

1.0

4.74

15.96

iu/ml

1.67

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

5.92

11.32

1.5

1.4

—

(44813793)

3.94

11.28

1.1

1.0

—

(3026008) Bacteria identified in Urine by Culture

665

5173

1.39

11.19

3.0

2.8

—

(3032080) INR in Blood by Coagulation assay

779

6227

1.37

11.05

8.9

7.5

1.23

1.24

inr

0.04

344

1795

(3002582) Erythrocytes [#/volume] in Urine

637

4929

1.39

11.04

3.3

2.8

68.74

105.73

e6/l

0.68

526

3651

(3009542) Hematocrit [Volume Fraction] of Blood

1591

17530

0.74

11.02

16.3

11.2

40.68

39.64

6.96

1183

12884

(3022948) Iron [Moles/volume] in Serum or Plasma

343

2373

1.52

10.74

2.7

2.1

14.21

13.74

umol/l

0.30

323

2187

(3000494) Fungus identified in Specimen by Culture

259

1685

1.60

10.66

1.4

1.3

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

3.95

10.30

1.5

1.2

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

674

5317

1.37

10.25

3.2

2.8

33.49

33.01

u/l

0.05

641

5065

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

4.56

10.24

1.1

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

4.56

10.24

1.1

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

4.56

10.24

1.1

1.2

—

(3007164) IgA [Mass/volume] in Serum or Plasma

447

3293

1.44

10.15

1.5

1.3

2.33

2.30

g/l

0.16

332

1969

(3021447) Carbon dioxide [Partial pressure] in Venous blood

213

1337

1.65

10.13

4.2

3.3

6.02

5.73

kpa

3.34

205

1299

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

315

2.32

10.00

1.3

1.1

—

(3021601) Nitrite [Presence] in Urine by Test strip

1034

8720

1.32

9.95

4.8

4.4

0.00

estimate

0.00

331

1565

(3022145) Colonoscopy Study observation

264

1753

1.57

9.94

1.3

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

379

2.18

9.60

1.8

0.79

3.42

ug/l

1.50

323

(3031040) Bacteria [#/volume] in Urine by Automated count

1339

11739

1.31

9.56

4.6

3.9

191.62

2378.29

e6/l

2.61

158

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

387

2816

1.44

9.34

3.8

3.0

238.74

526.52

ng/l

1.18

235

2105

(3009261) Glucose [Presence] in Urine by Test strip

1039

8822

1.31

9.32

3.8

3.3

0.00

0.01

estimate

0.39

317

1536

(3012494) Peanut IgE Ab [Units/volume] in Serum

4.70

9.29

1.1

1.83

6.41

u/ml

0.51

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

4.70

9.29

1.0

1.1

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

545

4213

1.38

9.28

2.3

2.1

3.06

2.88

mg/l

1.01

487

3557

(3004789) Transferrin [Mass/volume] in Serum or Plasma

308

2147

1.50

9.26

2.7

2.1

2.44

2.34

g/l

2.45

294

1985

(3011412) CD3 cells [#/volume] in Blood

3.40

9.17

1.6

2.3

1.10

1.15

e9/l

0.12

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

3.91

9.13

1.8

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

5.96

9.12

1.6

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

5.96

9.12

1.6

1.4

—

(3000850) Epithelial cells [#/volume] in Urine

445

3334

1.41

9.12

2.6

2.4

5.46

5.81

e6/l

0.30

388

2871

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.51

8.97

1.1

1.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.51

8.97

1.1

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

5.51

8.97

1.1

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

5.51

8.97

1.1

1.3

—

(3035350) Ketones [Presence] in Urine by Test strip

1024

8710

1.30

8.96

3.8

3.2

0.00

estimate

0.80

313

1545

(3015171) Extractable nuclear Ab [Units/volume] in Serum

515

1.96

8.86

1.3

1.2

0.15

1.06

u/ml

—

(3022313) Gas panel - Capillary blood

107

574

1.90

8.75

3.9

3.0

—

(3002032) Base excess in Venous blood by calculation

206

1330

1.60

8.75

4.2

3.3

2.21

1.49

mmol/l

1.64

169

1044

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

288

2007

1.49

8.65

2.8

2.2

24.25

23.82

0.15

249

1751

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1981

18466

1.37

8.55

17.0

9.6

19.04

21.74

mg/l

3.87

1711

13685

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1583

14301

1.30

8.50

4.0

3.8

14.82

14.71

pmol/l

1.08

1474

12943

(3018405) Lactate [Moles/volume] in Arterial blood

440

2.01

8.45

3.5

3.4

1.24

1.38

mmol/l

1.10

440

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

5.18

8.40

1.3

1.0

—

(3012544) pH of Venous blood

211

1384

1.57

8.38

4.2

3.3

—

7.38

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

173

2.63

8.27

1.3

1.4

268.08

271.20

pmol/l

0.03

133

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.59

8.12

1.6

2.1

11.43

15.05

0.73

(40767503) Oxygen content in Capillary blood by calculation

225

2.38

7.94

2.2

17.46

16.67

0.66

103

(3012095) Magnesium [Moles/volume] in Serum or Plasma

307

2207

1.45

7.85

3.3

2.8

0.82

mmol/l

0.15

284

2035

(3045424) Erythrocytes [Presence] in Urine

260

2.26

7.69

1.6

1.5

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

706

5819

1.30

7.53

3.3

2.9

—

(3035637) Corticotropin [Mass/volume] in Plasma

161

2.57

7.27

1.3

1.6

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

3.40

7.24

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

285

2053

1.44

7.20

2.3

127.00

126.36

ug/g

0.01

216

1614

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

334

2.06

7.20

1.6

—

(40768806) Pleura Pathology biopsy report

3.94

7.16

1.2

1.6

—

(3010421) pH of Blood

308

2.11

7.15

4.1

2.4

7.43

7.42

2.86

257

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

376

2.00

7.14

1.3

1.2

—

(3018095) Leukocytes [#/volume] in Urine

718

5966

1.29

7.12

4.0

3.2

83.61

118.63

e6/l

0.74

563

3977

(3014111) Lactate [Moles/volume] in Serum or Plasma

175

1144

1.57

7.07

6.3

5.7

1.43

1.39

mmol/l

0.17

154

1107

(3039000) Anion gap in Blood

264

2.19

7.02

4.6

5.6

11.10

11.34

mmol/l

0.20

233

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.87

6.98

1.6

1.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1340

12009

1.25

6.96

3.5

2.9

—

(3018572) Chloride [Moles/volume] in Blood

265

2.18

6.95

4.6

5.6

103.81

105.80

mmol/l

2.58

234

(3047181) Lactate [Moles/volume] in Blood

381

1.97

6.90

5.0

4.6

1.22

1.24

mmol/l

0.11

324

(3047007) Chlamydophila sp Ab [Presence] in Serum

167

2.48

6.76

1.4

1.2

—

(3025941) Bacteria identified in Stool by Culture

138

867

1.63

6.60

1.2

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1365

12301

1.24

6.58

4.5

3.7

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

465

3682

1.32

6.54

1.7

1.6

63547244.27

36172736.03

pmol/l

0.37

406

3041

(3015377) Calcium [Moles/volume] in Serum or Plasma

670

5573

1.28

6.49

3.0

2.8

2.35

2.36

mmol/l

1.10

601

4869

(3003338) MCHC [Mass/volume]

1518

16440

0.80

6.48

19.4

13.4

331.78

332.69

g/l

3.32

1504

16297

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

3.31

6.41

1.2

1.3

4.95

6.29

u/l

0.78

(3034891) Synovial lining cells/100 cells in Synovial fluid

3.31

6.41

1.6

1.4

—

2.93

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

209

2.27

6.41

1.2

1.1

14.08

10.43

au/ml

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

220

1551

1.46

6.24

3.8

238.96

245.29

u/l

0.24

214

1456

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

110

662

1.69

6.22

7.0

7.8

—

(3013637) Mi-2 Ab [Presence] in Serum

5.02

6.22

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

5.02

6.22

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

5.02

6.22

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

5.02

6.22

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

171

1146

1.53

6.21

4.5

2.9

4.99

4.50

kpa

1.13

164

1112

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

132

2.60

6.21

1.6

1.4

29.04

27.25

0.08

(44790048)

3.07

6.19

1.6

1.1

—

(44806118)

3.07

6.19

1.6

1.1

—

(44790049)

3.07

6.19

1.6

1.1

—

(44790047)

3.07

6.19

1.6

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

259

2.11

6.13

1.7

2.1

135.24

130.57

g/l

0.42

203

(3023323) Follitropin [Units/volume] in Serum or Plasma

126

789

1.63

6.12

1.4

21.94

26.95

iu/l

1.12

110

660

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

307

2.01

6.10

1.2

1.4

—

11.02

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

165

1109

1.52

5.92

2.3

2.0

11.73

11.76

nmol/l

0.01

139

985

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

290

2.02

5.91

3.3

2.3

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

256

1877

1.41

5.86

6.1

4.4

1.10

1.04

mmol/l

2.56

237

1733

(3012441) Differential panel - Pleural fluid

3.41

5.86

1.2

1.4

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

4.39

5.76

1.3

1.5

13.79

13.47

u/l

0.07

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

5.02

5.74

1.0

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

5.90

5.62

1.8

1.2

—

(3014891) Appearance of Pleural fluid

12.89

5.58

1.8

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1836

17253

1.25

5.40

14.9

9.9

83.80

82.07

ml/min/173m2

2.64

1607

13815

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

246

2.05

5.36

1.3

1.4

7.04

7.08

mmol/l

0.03

168

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

5.02

5.26

1.3

2.5

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

4.63

5.25

2.0

1.3

—

(3012501) Base excess in Blood by calculation

262

2.01

5.23

4.5

2.5

2.41

2.17

mmol/l

0.27

143

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

163

2.29

5.21

1.2

1.1

—

(3044889) 12 lead EKG panel

1353

12344

1.21

5.21

3.8

3.3

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

817

7110

1.22

5.05

6.4

4.6

1.21

1.22

mmol/l

0.45

754

6386

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.18

5.04

1.4

1.3

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

2.68

4.91

1.9

1.6

3.75

2.69

u/field

0.15

(3000034) Microalbumin [Mass/volume] in Urine

136

2.37

4.90

3.2

3.0

49.90

14.08

mg/l

0.49

103

(3000060) B lymphocytes [#/volume] in Blood

3.95

4.71

1.9

2.1

442.86

218.57

e6/l

—

(40760888) Immunoglobulin light chains.free panel - Serum

273

1.92

4.69

1.7

2.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

212

2.05

4.62

5.7

4.2

160.75

494.05

iu/ml

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

194

1415

1.40

4.61

2.5

2.1

0.21

g/l

0.44

183

1313

(3048929) Epstein Barr virus Ab [Presence] in Serum

445

1.71

4.56

1.3

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

230

1.97

4.40

1.1

1.2

39.67

24.45

u/l

0.75

202

(3030467) Casts [#/volume] in Urine by Automated count

530

4470

1.24

4.34

3.1

2.8

0.56

0.41

e6/l

0.63

420

3287

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

3.21

4.33

1.4

1.8

123.55

208.81

umol/l

0.56

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

3.35

4.32

2.9

1.6

524.80

1701.44

u/ml

1.28

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

155

2142

0.70

4.29

6.7

6.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

423

1.70

4.27

1.6

0.29

0.09

iu/ml

0.53

(40768804) Tissue Pathology biopsy report

800

7040

1.20

4.26

2.1

2.0

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

3.05

4.24

1.2

1.3

40696.67

10217.97

e6/l

0.97

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

474

3962

1.24

4.21

1.2

1.3

1.99

1.81

u/ml

0.11

173

1041

(3020630) Protein [Mass/volume] in Serum or Plasma

154

1097

1.43

4.20

2.1

67.00

67.07

g/l

0.05

141

973

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

2.75

4.18

1.4

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

134

934

1.46

4.11

1.6

1.9

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.76

4.08

1.8

1.1

—

(3020779) Urea [Moles/volume] in Serum or Plasma

163

1181

1.41

4.05

7.6

5.9

9.69

9.42

mmol/l

0.20

157

1118

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

162

2.11

4.03

1.8

1.6

63.61

62.35

0.06

103

(3018418) pH of Serum or Plasma

536

4564

1.22

3.98

4.6

3.2

7.39

7.40

1.03

145

849

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

2.64

3.89

1.1

1.2

1.12

13.93

nmol/l

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

412

1.67

3.88

1.8

1.7

—

(3020891) Body temperature

530

1.59

3.84

4.8

3.9

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

293

1.79

3.83

1.1

—

(3022689) Creatine [Moles/volume] in Urine

3.07

3.80

1.3

—

(3008536) Aspergillus sp Ab [Presence] in Serum

12.02

3.76

1.5

2.6

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1280

11817

1.17

3.74

3.1

2.7

48.01

41.69

u/l

2.16

1218

11047

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

303

1.77

3.73

1.3

1.2

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

624

1.53

3.69

7.5

7.8

24.25

23.69

mmol/l

1.01

585

(3004809) Band form neutrophils/100 leukocytes in Blood

189

1.97

3.68

3.7

3.5

3.57

1.45

0.77

146

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

391

1.65

3.56

1.9

2.4

2.90

1.66

ratio

0.42

(40758558) Short blood count panel - Blood

481

4094

1.22

3.56

7.6

5.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

165

2.01

3.49

1.3

—

nmol/l

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

1979

18998

1.21

3.47

17.6

11.9

3.96

mmol/l

0.13

1948

18361

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

379

1.65

3.45

1.6

1.4

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

384

3211

1.23

3.37

1.7

1.4

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

283

1.75

3.36

1.1

1.2

—

0.62

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

3.25

3.34

2.3

3.2

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

337

1.68

3.32

1.3

1.6

312.02

11175.68

e6/l

0.51

278

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.72

3.32

2.2

81.06

98.38

1.52

(3019977) pH of Arterial blood

2.93

3.29

2.2

1.9

7.38

7.42

—

(1002224) Polysomnography panel

608

1.50

3.29

1.1

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

1971

18941

1.20

3.28

17.4

11.8

139.52

139.76

mmol/l

3.90

1941

18349

(36304419) Bacteria [Presence] in Urine

508

4381

1.20

3.26

3.1

2.7

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

137

1003

1.39

3.26

3.0

3.4

4.38

4.51

pmol/l

1.19

129

883

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

441

1.58

3.24

2.1

816.26

959.84

ug/l

0.06

418

(3034274) Bile acid [Moles/volume] in Serum --fasting

257

1.76

3.22

1.8

2.2

5.52

7.85

umol/l

0.48

186

(21494814) CD8 cells/100 lymphocytes in Specimen

3.34

3.19

1.3

2.2

—

(3008037) Lactate [Moles/volume] in Venous blood

349

1.65

3.18

2.3

1.44

1.60

mmol/l

0.74

337

(3018677) aPTT in Platelet poor plasma by Coagulation assay

280

2276

1.26

3.18

2.3

1.9

29.41

29.56

0.19

274

2213

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

590

1.49

3.13

1.6

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

306

2518

1.25

3.12

3.3

2.6

4.41

2.48

e6/l

1.85

199

1339

(3013512) EKG study

551

4808

1.19

3.10

4.1

3.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

2.29

3.10

1.0

0.69

0.34

u/ml

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

132

1771

0.73

3.10

1.5

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

674

0.57

3.08

1.2

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

125

2.09

3.08

1.3

1.4

—

(4027681)

2.34

3.07

1.2

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

167

1.93

3.04

1.0

—

(3020874) Milk IgE Ab [Units/volume] in Serum

2.27

3.03

1.0

1.1

1.42

0.43

u/ml

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

161

1.94

2.99

2.7

3.8

17.00

41.49

u/ml

1.74

161

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

403

1.58

2.97

1.9

2.4

29.82

66.56

mg/l

1.22

335

(3034860) Kappa light chains.free [Mass/volume] in Serum

404

1.57

2.94

1.9

2.4

63.21

54.17

mg/l

0.19

332

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

526

1.50

2.91

1.9

1.7

3.70

3.90

g/l

0.45

366

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

526

1.50

2.91

1.9

1.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

526

1.50

2.91

1.9

1.7

7.27

7.40

g/l

0.26

389

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

2.38

2.89

1.2

2.1

675.17

706.33

e6/l

—

(3003327) Ova and parasites identified in Stool by Light microscopy

519

1.50

2.88

1.4

1.7

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

178

1.87

2.86

1.3

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

417

3574

1.20

2.86

1.8

1.9

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

275

1.69

2.84

1.7

1.3

—

(21494755) Public health laboratory ask at order entry panel

230

1853

1.27

2.83

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

337

1.62

2.83

1.2

1.5

31.31

20.27

e6/l

0.24

259

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

147

1119

1.33

2.78

3.8

3.3

92.45

83.00

ng/l

0.53

123

966

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

614

0.58

2.74

1.7

1.6

—

(3002385) Erythrocyte distribution width [Ratio]

1654

15752

1.15

2.74

20.2

12.6

13.84

13.54

10.85

1631

15329

(3009214) Lutropin [Units/volume] in Serum or Plasma

485

1.50

2.72

1.6

1.4

8.85

8.83

u/l

0.00

394

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

405

1.54

2.70

3.7

3.3

0.36

0.37

u/ml

0.08

227

(3021960) Folate [Moles/volume] in Serum or Plasma

450

3915

1.18

2.60

1.5

20.80

20.78

nmol/l

0.01

408

3326

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

245

2010

1.24

2.59

1.7

1.52

1.38

1.87

218

1789

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

166

2095

0.78

2.55

4.3

32.20

32.79

0.27

113

1398

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

710

1.40

2.55

5.7

3.7

24.12

23.66

mmol/l

0.60

639

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

101

2.09

2.52

1.1

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

380

1.54

2.51

1.3

1.4

485.36

504.72

mg/l

0.11

359

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

495

1.47

2.49

1.9

1.7

2.88

3.07

g/l

0.76

381

(3040151) Glucose [Moles/volume] in Capillary blood

151

1.86

2.47

4.2

4.4

7.84

6.82

mmol/l

0.33

127

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

326

1.58

2.46

1.2

1.4

3.59

3.66

mmol/l

0.20

307

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1185

0.72

2.44

1.4

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

139

1074

1.31

2.40

2.2

2.3

41.63

20.66

au/ml

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

402

1.50

2.37

5.3

4.2

1.49

1.35

mg/l

0.79

363

(3035880) pH of Pleural fluid

3.64

2.36

1.1

1.8

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.64

2.36

1.1

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

351

3021

1.19

2.30

3.1

2.7

2.46

2.45

mmol/l

1.13

309

2651

(3045788) Cell count panel - Pleural fluid

2.38

2.29

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1785

17174

1.14

2.28

4.8

4.4

1.91

2.09

mu/l

0.75

1683

15702

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.62

2.27

1.7

1.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.62

2.27

1.7

1.0

95.67

93.08

—

(3009508) Creatinine [Moles/volume] in Urine

587

5271

1.15

2.24

2.9

3.1

7.76

7.49

mmol/l

0.67

522

4455

(3045414) Leukocytes [Presence] in Urine

104

779

1.35

2.24

1.9

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

504

0.59

2.22

1.4

1.5

—

(3030313) Adrenal Ab [Titer] in Serum

5.56

2.21

1.0

—

(3007566) Smooth muscle Ab [Titer] in Serum

417

1.47

2.20

1.1

1.2

53.33

75.29

titre

—

(3042733) HLA Ab [Presence] in Serum

3.01

2.14

4.3

3.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

453

1.45

2.14

2.0

1.8

0.48

0.83

g/l

0.59

382

(3017143) Hepatitis C virus Ab [Presence] in Serum

234

1955

1.22

2.12

1.6

1.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

908

8414

1.12

2.11

4.2

3.7

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

267

2262

1.20

2.10

2.1

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

221

1840

1.22

2.08

1.5

1.3

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.08

2.06

1.1

1.0

1.07

1.20

u/l

—

(3052592) Norovirus Ag [Presence] in Stool

4.01

2.04

2.5

1.0

—

(40768443) Skin Pathology biopsy report

681

1.35

2.00

1.2

—

(3024932) HLA-DR beta [Type]

2.82

2.00

1.0

1.1

—

(3038515) Glucose [Moles/volume] in Venous blood

328

1.50

1.99

2.4

7.06

7.64

mmol/l

0.95

319

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

207

1722

1.22

1.97

3.2

2.4

8.66

8.62

umol/l

0.01

179

1480

(3020393) Adenovirus Ag [Presence] in Stool

3.34

1.96

1.6

1.1

—

(40757373) Influenza virus identified in Isolate

4.55

1.94

1.6

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

142

1.77

1.92

1.0

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

113

1.87

1.91

1.3

1.6

—

(3020961) Endomysium IgA Ab [Titer] in Serum

112

871

1.30

1.90

1.1

138.33

170.70

titre

—

(3005570) Glucose [Moles/volume] in Urine

188

1.66

1.90

2.3

1.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

227

1.59

1.90

1.2

1.3

21.11

23.04

u/l

0.16

195

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1726

16649

1.12

1.87

5.6

5.2

39.68

39.05

mmol/mol

2.31

1645

15398

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

261

1.54

1.84

1.7

1.3

103.75

103.67

u/ml

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

359

4064

0.86

1.83

3.7

3.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

402

1.43

1.81

1.5

1.4

326.62

291.90

ug/g

0.78

217

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

3.05

1.80

1.3

1.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

3.05

1.80

1.3

1.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

3.05

1.80

1.3

1.4

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

695

1.32

1.78

1.6

286.48

298.47

mu/l

0.16

629

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

162

1.67

1.74

1.8

1.9

1.10

1.53

u/field

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

3.34

1.74

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

2.92

1.72

1.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.92

1.72

1.0

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

3.85

1.71

39.4

7.5

5.12

6.35

mmol/l

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

1.96

1.69

1.4

1.5

—

92.00

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

220

1.55

1.65

1.1

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

2.80

1.65

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

288

2513

1.17

1.64

2.2

2.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

1.93

1.64

1.0

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.58

1.61

1.4

1.2

—

(3024471) HLA-A [Type]

2.50

1.59

1.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.95

1.59

2.9

2.2

—

(44806071)

3.00

1.58

1.2

1.0

—

(3023511) Choriogonadotropin [Units/volume] in Urine

405

1.39

1.58

1.6

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

346

1.42

1.58

1.1

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

239

1.51

1.57

1.2

5.58

5.34

u/ml

0.02

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

1.89

1.54

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

158

0.44

1.54

1.1

379.86

346.14

nmol/l

—

140

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

189

1603

1.19

1.53

3.2

3.8

5.19

43.66

ug/l

1.14

164

1290

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

100

1.81

1.53

1.3

24.37

491.29

pmol/l

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

100

1.81

1.53

2.2

1.4

18.17

19.25

u/ml

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

3.34

1.52

1.0

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

241

1.50

1.52

1.8

1.7

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

225

1.52

1.51

1.2

3.09

4.01

u/ml

0.45

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

101

1.79

1.48

1.1

1.2

1.09

1.04

ratio

—

(40761535) Cells panel - Urine sediment

109

1344

0.80

1.47

3.7

3.1

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

489

1.34

1.46

2.0

1.7

9.99

10.29

g/l

0.22

408

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.84

1.45

1.2

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

164

1.59

1.43

1.4

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

388

1.37

1.42

2.1

2.3

116.53

85.70

ug/min

0.25

231

(21494890) Protein electrophoresis panel - 24 hour Urine

118

1.70

1.41

1.4

1.6

—

(3020682) Albumin/Creatinine [Ratio] in Urine

549

5051

1.11

1.39

3.5

3.9

7.35

7.83

mg/mmol

0.11

382

3115

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.42

1.39

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.42

1.39

1.0

—

(3017732) Neutrophils [#/volume] in Blood

131

1084

1.22

1.39

2.5

2.6

4.45

3.87

e9/l

2.12

107

857

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

661

1.28

1.38

4.6

2.6

1.47

1.21

0.96

651

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

748

6995

1.10

1.37

1.9

96.46

96.16

pmol/l

0.06

418

3583

(3000991) Gas panel - Venous blood

138

1150

1.21

1.37

7.3

6.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.20

1.37

1.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.20

1.37

1.0

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.20

1.37

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.83

1.35

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.83

1.35

1.1

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.83

1.35

1.1

1.0

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

366

1.37

1.35

1.2

1.3

2.72

8.28

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

349

1.38

1.35

1.6

8337.83

13823.66

e6/l

0.81

250

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

2.13

1.33

2.1

2.2

7.33

9.24

mg/l

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

224

1.48

1.33

1.2

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

146

1227

1.20

1.33

1.2

123.55

142.51

iu/ml

0.25

468

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

242

1.45

1.30

3.1

3.8

58.34

56.59

0.42

242

(3014765) Yersinia sp identified in Stool by Organism specific culture

447

1.33

1.29

1.2

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

226

1.47

1.28

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

448

0.69

1.27

1.6

1.4

64.62

143.34

pmol/l

1.46

438

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.94

1.27

1.2

1.1

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.00

1.27

2.4

2.7

38.60

36.84

—

(3037756) Immunofixation for Serum or Plasma

261

1.42

1.25

1.3

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

450

1.32

1.24

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

2.40

1.24

1.7

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.40

1.24

1.0

—

(3036489) Thrombin time

556

1.28

1.24

3.0

1.9

21.28

21.19

0.04

480

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.86

1.23

1.2

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

147

1.57

1.23

1.1

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

443

1.32

1.21

1.2

1.1

—

(3027944) Amphetamines [Presence] in Urine

802

1.23

1.19

2.2

1.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

247

1.42

1.19

1.1

2.36

3.58

u/ml

0.31

113

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.00

1.16

1.0

1.1

—

(4281824)

185

0.54

1.15

1.0

1.1

—

(3019150) Specific gravity of Urine by Refractometry

423

3884

1.11

1.13

3.9

3.6

1.02

kg/l

0.58

575

(3027456) Digoxin [Moles/volume] in Serum or Plasma

250

1.41

1.12

3.3

2.9

0.77

0.83

nmol/l

0.37

188

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.34

1.12

2.9

1.9

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

2.34

1.12

2.9

1.9

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

134

1139

1.19

1.12

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.90

1.12

7.5

3.0

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

101

1213

0.83

1.11

1.4

1.5

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

144

1234

1.18

1.10

1.3

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.95

1.08

1.0

1.2

—

(3049717) Cytology report of Urine Cyto stain

604

1.25

1.07

3.7

2.5

—

(3028300) Cannabinoids [Presence] in Urine

822

1.21

1.07

2.2

1.8

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

2.12

1.05

1.0

1.2

111.29

98.11

—

(3000764) Benzodiazepines [Presence] in Urine

815

1.21

1.05

2.2

1.8

—

(3034426) Prothrombin time (PT)

1.96

1.03

1.4

1.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.27

1.03

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

179

1.46

1.03

1.2

1.3

—

(1617658) Protocol used for examination of sentinel lymph nodes

151

0.53

1.02

1.0

—

(3012516) Albumin [Mass/volume] in Urine

513

4779

1.09

1.02

2.8

3.1

416.82

221.11

mg/l

0.43

338

2900

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

754

1.21

1.01

2.1

1.4

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

563

0.76

1.01

1.5

1.7

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

143

1235

1.17

1.01

2.1

4.20

7.39

ug/l

4.11

127

1074

(3027008) Opiates [Presence] in Urine

820

1.20

0.99

2.1

1.8

—

(3003181) Sodium [Moles/volume] in Urine

231

1.39

0.99

1.3

66.60

65.20

mmol/l

0.08

190

(3045683) HLA typing for celiac disease panel - Blood or Tissue

115

1.57

0.99

1.1

1.0

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.18

0.98

1.2

1.1

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

630

1.23

0.98

1.4

1.6

1.59

1.50

g/l

0.36

531

(3044007) Cell count panel - Peritoneal fluid

1.95

0.97

1.1

1.9

—

(3014271) Vancomycin [Susceptibility]

1.85

0.96

2.7

2.6

—

(3016879) Cocaine [Presence] in Urine

750

1.21

0.96

2.0

1.9

—

(4035726)

155

1354

1.15

0.95

1.2

1.3

—

(3050129) First trimester maternal screen panel - Serum or Plasma

779

0.80

0.95

1.4

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

117

0.51

0.94

1.0

545.50

358.58

ng/l

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

118

0.51

0.94

1.0

71.83

48.47

ng/l

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

125

1.52

0.93

1.2

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

2.22

0.93

1.5

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.22

0.93

1.2

1.0

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.73

0.92

1.8

1.4

—

(3003694) ABO and Rh group [Type] in Blood

521

5548

0.92

0.91

1.5

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

176

1.42

0.90

1.2

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

432

4634

0.92

0.90

1.5

1.6

1.47

1.31

mmol/l

3.18

380

3908

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

2.07

0.89

1.2

1.1

99.15

36.99

u/ml

—

(40768795) Lymph node Pathology biopsy report

155

0.58

0.88

1.2

1.1

—

(3024263) Appearance of Synovial fluid

1.65

0.88

1.9

1.8

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

272

1.33

0.87

1.4

1.2

216.12

228.55

u/ml

0.15

151

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

136

1.47

0.86

1.2

1.1

55.50

60.80

u/l

0.18

(3004716) Salmonella sp identified in Stool by Organism specific culture

113

974

1.17

0.85

1.4

—

(3019309) Folate [Moles/volume] in Red Blood Cells

322

2964

1.10

0.85

1.6

1.7

1269.19

1151.51

nmol/l

1.38

254

2233

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

163

1444

1.14

0.84

1.9

2.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

335

1.29

0.84

1.3

1.5

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

291

1.31

0.84

1.4

1.2

—

(3028433) Virus identified in Specimen by Culture

1.94

0.84

1.0

1.1

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.74

0.82

1.4

1.1

—

(3011288) Drugs identified in Urine by Screen method

554

1.21

0.81

2.9

2.5

—

(3023520) Reticulocytes [#/volume] in Blood

142

1253

1.14

0.79

2.2

2.4

74.02

66.97

e9/l

1.53

117

940

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

0.00

0.79

0.0

2.1

—

169.89

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

199

1.36

0.78

1.0

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

260

1.31

0.78

1.4

1.2

—

(4306422)

234

1.33

0.77

1.1

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.77

0.76

3.8

2.9

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.77

0.76

1.3

2.4

—

(40768800) Prostate Pathology biopsy report

325

0.74

0.76

1.3

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

115

1005

1.15

0.75

1.8

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

423

1.23

0.74

2.2

1.7

39.39

38.12

g/l

0.82

346

(3027945) Reticulocytes/100 erythrocytes in Blood

187

1688

1.12

0.74

2.8

2.3

1.81

1.71

0.70

172

1487

(3017354) Segmented neutrophils/100 leukocytes in Blood

116

1.47

0.74

2.2

3.4

62.82

55.82

0.39

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.92

0.70

1.6

1.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

787

1.16

0.69

2.6

2.0

3302.88

6330.59

u/l

0.87

329

(3024522) Salmonella sp identified in Specimen by Organism specific culture

178

1.35

0.68

1.2

1.3

—

(3011436) Histone Ab [Units/volume] in Serum

1.85

0.68

1.2

1.1

—

(40768446) Kidney Pathology biopsy report

1.67

0.68

1.3

1.5

—

(4133840)

1.67

0.68

1.1

1.2

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

119

0.59

0.67

1.0

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

119

1.43

0.66

2.2

2.5

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

493

0.81

0.65

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

2000

19738

1.07

0.65

15.3

9.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

503

0.81

0.64

1.3

1.5

—

(40768793) Breast Pathology biopsy report

425

0.80

0.63

1.2

1.4

—

(3005033) Fetal Nuchal fold Thickness US

490

0.81

0.62

1.3

1.4

—

(40768441) Liver Pathology biopsy report

121

1.41

0.62

1.3

—

(40761536) Microorganisms panel - Urine sediment

135

1499

0.89

0.61

4.5

3.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.60

0.61

1.8

1.3

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

174

1.32

0.60

1.2

1.3

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

677

1.16

0.59

1.4

—

(3044290) Cell count panel - Cerebral spinal fluid

299

1.24

0.59

1.1

1.5

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

0.00

0.59

0.0

1.0

—

(3008898) HLA-B27 [Presence]

575

1.17

0.59

1.0

1.1

—

(3023410) Appearance of Cerebral spinal fluid

157

1.34

0.59

1.4

1.9

—

(3028707) Methadone [Presence] in Urine by Screen method

327

1.23

0.58

3.4

2.4

—

(3004451) EKG impression Narrative

1.51

0.58

1.5

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

428

1.20

0.58

1.9

2.0

2.33

4.90

iu/l

2.92

166

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.48

0.57

1.1

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

571

0.84

0.57

2.3

3.0

53.90

855.23

u/ml

1.37

477

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

211

1.28

0.57

1.5

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

176

1.31

0.56

1.2

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

176

1.31

0.56

1.2

1.3

—

(1761868) Lipid panel - Serum or Plasma

697

6712

1.05

0.55

2.4

2.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

600

0.85

0.54

1.3

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.58

0.54

1.0

—

(3000963) Hemoglobin [Mass/volume] in Blood

2127

21455

0.94

0.53

23.1

15.5

135.54

135.21

g/l

0.48

2114

21093

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

599

0.85

0.53

1.3

1.4

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

128

1159

1.11

0.53

1.7

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

0.62

0.52

1.5

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

597

0.85

0.52

1.3

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

597

0.85

0.52

1.3

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

219

2037

1.08

0.51

1.9

1.7

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

1.50

0.51

1.0

1.1

—

(3002256) Pathology report gross observation

213

2285

0.93

0.50

1.3

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

142

1298

1.10

0.50

2.7

2.4

70.46

67.95

ml/min/173m2

0.33

522

(3026361) Erythrocytes [#/volume] in Blood

2127

21445

0.94

0.49

22.9

15.4

4.52

4.50

e12/l

1.57

2100

20719

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

252

1.23

0.49

1.1

—

(3000012) Reticulocyte production index

1.43

0.49

1.0

1.4

—

(3010813) Leukocytes [#/volume] in Blood

2128

21453

0.94

0.49

23.0

15.4

7.18

6.55

e9/l

19.25

2101

20722

(3035941) MCH [Entitic mass]

2127

21443

0.94

0.49

22.8

15.3

30.12

30.23

1.99

2111

21075

(3024731) MCV [Entitic volume]

2127

21443

0.94

0.49

22.9

15.4

90.78

90.66

0.52

2111

21075

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

301

0.80

0.49

1.3

1.2

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.52

0.48

1.7

1.0

59.90

63.71

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

634

1.14

0.48

2.7

1.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.38

0.46

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.38

0.46

1.2

1.1

—

(3036603) Volume of Urine

1.43

0.45

1.4

1.5

1819.60

1881.56

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.37

0.44

1.0

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.37

0.44

1.0

1.2

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.37

0.44

1.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

315

2990

1.06

0.44

1.6

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.37

0.43

1.2

1.1

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.41

0.43

1.4

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

1.56

0.42

1.2

—

(3007461) Platelets [#/volume] in Blood

2127

21423

0.95

0.41

23.0

15.4

264.07

250.43

e9/l

16.66

2101

20752

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.41

0.0

1.0

—

(3019174) dRVVT (LA screen)

0.00

0.41

0.0

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.00

0.41

0.0

1.3

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.40

0.0

1.2

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.39

0.40

1.1

1505.45

1601.84

miu/ml

0.13

(3051101) Glucose [Moles/volume] in Cord blood

1.47

0.40

5.6

6.9

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

352

1.17

0.40

1.4

2.1

0.86

0.72

nmol/l

0.71

297

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.40

0.0

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

223

1.21

0.39

1.1

—

(3026470) Cobalt [Mass/volume] in Blood

104

0.67

0.39

1.4

2.0

0.60

2.91

ug/l

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

1.41

0.39

1.6

1.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

1.41

0.39

1.6

1.5

—

(21494434) Karyotype in Bone marrow

133

1.28

0.38

1.8

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.32

0.37

1.0

1.2

—

(3044640) Blood type and Crossmatch panel - Blood

558

5401

1.04

0.37

2.8

2.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.33

0.37

1.0

1.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.33

0.37

1.2

2.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

125

1.28

0.37

5.3

3.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

1.36

0.36

1.7

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.27

0.36

1.0

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

0.63

0.35

1.4

1.2

—

(3023420) DNA double strand Ab [Units/volume] in Serum

135

1.26

0.35

1.5

1.4

—

32.60

—

(3051651) Icteric interference index of Serum or Plasma

1.37

0.34

3.4

3.7

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.36

0.34

1.3

1.1

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.32

0.33

1.3

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

275

2876

0.95

0.33

2.9

3.1

0.72

0.83

ug/l

1.22

162

1920

(3039443) Prostate specific Ag panel - Serum or Plasma

264

0.83

0.33

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

128

1.25

0.31

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

119

1.26

0.31

1.0

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

446

1.12

0.31

3.7

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

176

1667

1.06

0.30

3.4

2.7

—

(3025130) Human papilloma virus identified in Specimen

259

0.85

0.28

1.5

1.7

—

(4034850)

565

1.10

0.28

6.3

9.8

—

(3047189) Immunofixation for 24 hour Urine

1.25

0.27

1.4

1.3

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

319

1.13

0.26

1.4

1.2

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1802

17877

1.03

0.25

4.3

4.1

5.87

5.84

mmol/l

0.49

1699

16250

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

226

1.15

0.24

1.1

127.19

116.54

0.57

201

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

105

1.24

0.24

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.25

0.24

1.3

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.25

0.24

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.25

0.24

1.3

1.1

—

(3006653) Thiamine [Moles/volume] in Blood

1.17

0.24

1.0

1.1

152.66

131.25

nmol/l

—

(3052851) Hemolysis interference index of Serum or Plasma

422

0.90

0.23

3.1

2.9

—

(4024509)

171

1.17

0.23

1.6

1.5

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1760

17464

1.03

0.23

3.7

3.6

1.33

1.24

mmol/l

5.13

1658

16024

(3048879) Bone marrow aspiration report

1.28

0.23

1.0

1.5

—

(3033799) Differential panel - Peritoneal fluid

1.28

0.23

2.6

1.9

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

1.25

0.22

1.2

1.1

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

1.27

0.22

1.1

1.3

120.10

257.18

u/l

—

(3009871) Measles virus Ab [Titer] in Serum

1.22

0.22

1.6

1.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

316

3254

0.97

0.21

1.5

1.4

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

343.20

—

(3003932) Carbon dioxide [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.1

—

8.30

—

(3004959) Base excess in Arterial cord blood by calculation

0.00

0.21

0.0

1.1

—

(3021706) Oxygen [Partial pressure] in Arterial cord blood

0.00

0.21

0.0

1.1

—

3.00

—

(3006598) pH of Arterial cord blood

0.00

0.21

0.0

1.1

—

(3022725) Serotonin [Moles/volume] in Serum

0.00

0.21

0.0

1.7

—

733.64

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.21

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

135

1.19

0.21

1.3

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

104

983

1.06

0.21

1.1

1.0

—

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

296

1.12

0.21

1.0

1.1

1.64

1873.54

iu/ml

0.51

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

103

0.78

0.21

1.1

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.00

0.21

0.0

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

1.1

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.20

0.0

1.9

—

1.48

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

0.20

0.0

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

606

1.07

0.20

1.3

171.13

222.00

miu/ml

0.93

289

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

292

0.89

0.20

3.4

2.8

34.75

28.32

u/ml

0.18

281

(3020650) Glucose [Presence] in Urine

1.18

0.19

1.2

1.6

—

(3037121) Protein [Mass/volume] in Urine

549

1.08

0.19

4.3

2.8

0.23

0.24

g/l

0.12

208

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

356

1.10

0.19

1.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

109

1.19

0.18

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

856

0.94

0.17

2.4

—

(4094501)

406

1.08

0.17

1.2

1.1

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

233

1.12

0.17

2.6

1.5

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.15

0.17

1.7

2.1

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2013

20034

1.02

0.17

10.4

8.3

28.44

25.36

u/l

2.03

1972

19215

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

262

2692

0.97

0.17

2.9

2.5

2.48

1.40

e6/l

0.36

154

1495

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

1.11

0.17

1.6

2.0

—

206.40

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

1.11

0.17

1.6

1.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.11

0.17

3.3

3.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.76

0.17

1.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

0.75

0.17

1.0

1.1

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

186

1.13

0.16

2.2

2.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1809

18184

0.98

0.16

4.0

1.48

1.49

mmol/l

0.79

1720

16798

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

288

0.90

0.16

1.3

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

387

3951

0.98

0.16

4.2

4.4

20.55

22.11

1.15

161

1993

(3003740) Influenza virus B Ag [Presence] in Specimen

263

1.10

0.16

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

263

1.10

0.16

1.1

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

720

0.94

0.16

1.5

1.4

3.28

2.60

mg/l

0.38

484

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.20

0.16

1.5

—

(3014051) Protein [Presence] in Urine by Test strip

428

1.08

0.16

2.4

2.0

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

216

1.11

0.15

1.3

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.13

0.15

1.0

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

226

1.11

0.15

2.5

2.4

3.98

1814.59

u/ml

0.75

211

(3044927) Protein electrophoresis panel - Urine

140

1.14

0.15

1.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1826

18344

0.98

0.15

4.1

4.0

4.64

4.68

mmol/l

1.11

1736

17034

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

103

1.17

0.13

1.0

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

180

0.89

0.13

3.1

1.9

37.40

29.65

mg/l

—

(3035320) C reactive protein [Mass/volume] in Body fluid

107

0.84

0.13

3.4

1.9

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.18

0.12

1.4

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

210

1.10

0.12

1.5

1.2

—

(3045142) Bone marrow Pathology biopsy report

173

1.10

0.10

1.7

1.3

—

(3000330) Specific gravity of Urine by Test strip

909

1.04

0.10

3.6

3.0

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.11

0.09

1.0

1.2

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

488

4936

0.99

0.09

4.8

5.1

2.87

4.40

ug/l

0.90

447

4409

(3051611) Lipemic interference index of Serum or Plasma

155

0.90

0.09

3.2

3.1

—

(4268621)

155

1.10

0.09

2.5

2.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

380

0.95

0.09

4.6

3.1

26.76

27.13

mg/l

0.02

235

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

126

1.11

0.09

1.5

1.7

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

512

0.96

0.08

1.4

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

146

1428

1.02

0.08

2.5

2.2

30.50

75.21

u/l

0.73

123

1214

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

0.83

0.08

8.8

4.6

7.13

8.51

mg/l

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.81

0.08

1.0

1.1

—

(3044941) Cell count panel - Synovial fluid

236

0.93

0.08

1.5

1.4

—

(4198724)

1.04

0.07

5.7

1.6

—

(3016018) Differential panel - Cerebral spinal fluid

147

1.09

0.07

1.3

1.8

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1861

18651

0.99

0.07

4.4

4.5

2.72

2.78

mmol/l

1.84

1759

17190

(3015183) Erythrocyte sedimentation rate

1.12

0.06

1.1

1.2

—

(3019832) Treponema pallidum Ab [Presence] in Serum

217

2200

0.98

0.06

1.6

1.7

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

528

0.96

0.06

2.0

1.8

—

(4146454)

172

0.93

0.06

2.4

2.7

—

(3021788) Differential panel - Synovial fluid

253

0.95

0.05

1.5

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

150

1.07

0.04

1.0

1.3

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

408

4105

0.99

0.04

2.5

2.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

637

1.02

0.03

1.8

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

159

0.94

0.03

1.3

1.5

—

(36660697) Celiac disease serology panel - Serum

139

1403

0.99

0.02

1.1

—

(3015736) pH of Urine

671

6689

1.00

0.02

3.3

3.1

—

5.71

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

641

1.01

0.01

1.4

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

163

1.04

0.01

1.9

2.6

—

(3019225) pH of Specimen

162

1610

1.01

0.01

3.3

3.6

—

(3024928) Oxygen saturation in Venous blood

283

1.02

0.01

7.9

3.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

105

0.95

0.00

5.7

6.9

—

(3032773) Endomysium IgG Ab [Titer] in Serum

161

0.99

0.00

1.1

—

(3022621) pH of Urine by Test strip

119

1193

1.00

0.00

2.8

2.9

—

(3033658) Prothrombin time (PT) actual/Normal

406

4056

1.00

0.00

4.1

3.2

92.28

90.67

0.61

393

3945

(3011648) Oxygen content in Venous blood

111

0.99

0.00

15.4

4.2

10.55

10.75

0.05

111

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

274

0.98

0.00

1.4

0.28

0.32

nmol/l

0.19

222

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.88

0.00

1.0

1.2

—

(3051593) INR in Capillary blood by Coagulation assay

0.91

0.00

8.3

15.9

—

(3013762) Body weight Measured

0.00

0.0

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.99

0.00

2.6

4.4

—

74.36

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

0.00

0.0

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

0.00

0.0

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.02

0.00

1.4

1.3

7.57

9.53

ug/l

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.0

1.8

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.3

—

3.48

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3018291) Platelet Ab [Presence] in Serum

0.00

0.0

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

4.7

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

6.4

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3035933) Granulocytes/100 leukocytes in Blood

0.93

0.00

1.0

1.4

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.86

0.00

1.0

1.1

—

(3017704) Immunofixation for Urine

0.94

0.00

1.2

1.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.0

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

543.16

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: ASTHMA_MIXED – Asthma mixed form (mode)

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Asthma mixed form (mode)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Asthma mixed form (mode) (ASTHMA_MIXED)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints